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Abstract 
The role of clinical engineers is rapidly changing and the economic constraints have pulled 
them towards new responsibilities to manage. Particularly, the assessment of health technologies has covered one of the most important areas among clinical engineersǯ duties. 
Different techniques and methodologies for technology assessment and improvement are 
available in the literature and they are currently in use within hospitals and healthcare facilities. 
However, scientific research and practical needs seem to be misaligned, causing misuse of 
scientific results due to the lack of tools easy-to-use from practical perspective. 
This thesis aims at integrating methodologies, even derived from different sectors, for 
providing standardized and versatile tools that overcome the current issues, providing 
healthcare facility with a path to follow for choosing the best methodology to be used in diverse 
situations. 
Different case studies are presented, in order to cover the wide range of possibilities within 
health technology assessment (HTA). Particularly, technology assessment was performed on 
medical devices using both Hospital-Based HTA for an existing technology and horizon scanning 
for designing an innovative solution. Then the assessment was extended to hospital services, 
with particular attention to clinical engineering services, using Multi-Criteria Decision Analysis. 
Process improvement methodologies were also considered and applied to sterilization service 
that was also studied and assessed integrating the classical HTA approach with Multi-Criteria 
Decision Analysis. 
These studies allowed to identify a path useful from practical perspective and based on 
scientific approach aimed at helping healthcare professionals and clinical engineers to choose 
the best methodology in accordance to specific constraints and needs of particular situations. 
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Introduction 
Clinical engineersǯ role is multifaceted, and they are in charge of diverse tasks, ranging from 
supervision of clinical engineering department, acquisition and management of medical devices, 
to the evaluation of health technology, as well as training of medical personnel and coordination 
of outside services and vendors. Clinical Engineering Departments are established in many 
hospitals worldwide, with the primary objective to provide a broad-based engineering program 
that addresses all aspects of medical instrumentation and system support. 
However, the practice of Clinical Engineering has changed enormously from its early days to 
the present, mainly due to the economic pressures that hospitals face, and the rapid 
development of highly complex instruments (e.g., MRI systems, surgical lasers). For this reason, 
assessment, acquisition and use of new technologies have played an increasing important role 
for clinical engineers, pushing them towards operational areas. In addition to technology 
assessment, clinical engineers are increasingly involved in process improvement, exploiting 
different techniques and approaches (e.g., lean management) aimed at reducing wastes and 
improving quality of service. Indeed, today clinical engineers are becoming heavily involved in 
strategic planning, technology assessment, and process improvement. 
However, even though many tools are currently in use, standardized and versatile 
methodologies for assessing technologies and improving processes are not available. This is due 
to the heterogeneity of healthcare context, in terms of specific constraints of hospitals, multitude 
of involved actors, and diversity of technologies. 
The research conducted within the present thesis, aimed at exploring tools and 
methodologies currently available and testing their application on different health technologies 
and services, with the final goal of adapting existing tools to innovative methodologies, in order 
to provide easy-to-use tools based on scientific findings but actually useful for practical needs of 
healthcare end-users. 
The document is structured as follow. 
The research question paragraph describes the workflow followed in the present work and 
presents the main research question the study aimed to address. 
The first chapter introduces the state-of-the-art in terms of tools currently used within the 
healthcare domain for assessing technologies and making decisions. Particularly, it focuses on 
Health Technology Assessment and Multi-Criteria Decision Analysis since they are increasingly 
used in healthcare domain, and they have been demonstrated to be reliable. Technology 
Assessment will be described starting from its origin, underlying further steps of its implementation within healthcare technologies. The term ǲhealth technologyǳ will be described 
in detail, since it has been debated in the literature, and the aim of the present work was to apply 
assessment tools on diverse technologies available in healthcare settings, including also 
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technologies usually not included in Health Technology Assessment (i.e., hospital services). 
Among the Multi-Criteria Decision Analysis tools, PAPRIKA will be presented, since it has been demonstrated to be one of the easiest tools among the others from decision makersǯ perspective.  
The second chapter focuses on assessment of medical devices. It is divided into two main 
sections. The first section presents a medical device already in the market, used for surgical 
operations. The assessment was conducted through Hospital-Based Technology Assessment, in 
an Italian hospital, driven from the need of finding the best technology to be used in 
thyroidectomy. The analysis was performed through the typical approach of Health Technology 
Assessment, and considering Break Even Point calculated on the constraints of the hospital. The 
second section follows an approach similar to Horizon Scanning: a particular methodology used 
within Health Technology Assessment dedicated to technology not yet in the market. A 
preliminary study for assessing the innovative technology is presented. The proposed solution 
was designed with the support of the Biomedical and Clinical Engineering Group of the 
University of Trieste: it aims to improve awareness of patients with chronic conditions, and it is 
described within this chapter. 
The third chapter focuses on a different kind of health technologies: hospital services. 
Indeed, enlarging the definition of health technology, hospital services can be considered as health technologies as well or, at least, ǲtechnology assetsǳ that may fall into the field of interest 
of Health Technology Assessment. This chapter is divided into three sections: the first one is 
dedicated to the assessment of a clinical engineering department of an Italian healthcare facility 
through the usage of Multi-Criteria Decision Analysis; the second one focuses on the 
implementation and combination of different approaches for process improvement (e.g., lean 
management, goal question metric), for describing and analyzing the process of surgical tools in 
an Italian hospital; the third section combines the acquired know-how of both Central Sterile 
Supply Department (CSSD) domain and Multi-Criteria Decision Analysis, through the application 
of PAPRIKA within a CSSD of an Italian health authority. Moreover, in the third section of this 
chapter, a comprehensive methodology for applying Health Technology Assessment through 
PAPRIKA in the specific context of hospital service is proposed. 
The fourth section briefly describes how assessment of medical equipment is currently 
managed in Low Income Countries, underlining the major issues at the state-of-the-art, 
proposing a possible solution aimed at overcoming the main challenges. 
In the last section, conclusions of the research are presented and a possible path for 
choosing the best methodology for assessing and improving health technologies is proposed. 
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Research question 
The following questions, that reflect the workflow of the present thesis, are addressed in the 
present work: 
 What are the current main challenges of using HTA? 
 How health technologies with no available previous data can be assessed? 
 What are the main differences in using HTA approach on different technologies? 
 Can HTA approach be useful for designing an innovative health technology? 
 How process improvement techniques can be applied within the healthcare domain? 
 Can ǲhealth technologyǳ definition be extended to hospital services? 
The previous questions, together with the main challenges highlighted in the literature, 
brought at the definition of the following main research question: 
 Is it possible to integrate methodologies, even derived from different sectors, for 
providing standardized and versatile tools that overcome the current issues for 
technology assessment and process improvement? 
 
 
   CHAPTER 1  
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Chapter 1 
Overall state-of-the-art 
This chapter briefly introduces methods for assessing technologies increasingly used within 
the healthcare system. Indeed, decision makersǯ need of providing comprehensive and objective 
evaluation on technologies acquisition prioritization has been accompanied by the development 
of methods and tools such as Health Technology Assessment (HTA) and Multi-Criteria Decision 
Analysis (MCDA). The term ǲtechnologyǳ has changed during years, enlarging its primary 
meaning. As a consequence, HTA has started to assess a variety of diverse technologies, with no 
standardized methods. On the other hand, MCDAs have started to be used and to be considered 
of support to decision makers for basing their decisions on solid and rigorous approach. In the 
recent years, the introduction of MCDAs within HTA has been increased, since it provides a 
prompt technology assessment, based on scientific findings, through a lean approach.  
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1.1. Technology Assessment 
1.1.1. Origin of Health Technology Assessment 
In the last decades, the market for health technology has been reinforced due to different 
factors such as advances in science and engineering, aging population, increasing prevalence of 
chronic diseases, providersǯ competition, and malpractice avoidance. On the other hand, the 
attention to reducing expenditure and, at the same time, improving quality of assistance, as well 
as balancing technological advances with the available resources, has become a huge challenge to 
be faced. The leading actors who influence the development, adoption, and diffusion of 
technologies are a widening group of policy makers working in the healthcare sector. In order to 
answer the demand of assessing technologies to be designed and adopted, and to help decision 
makers within this process, Health Technology Assessment (HTA) was developed and it is 
commonly used in different healthcare contexts. 
Technology assessment (TA) arose in the mid-1960s with the purpose to assess 
technologies for their potential unintended and harmful consequences (e.g., effects related to 
chemical, industrial processes, pollution, and weather modification). Both direct (i.e., caused by 
technology itself) and indirect consequences (i.e., unintended social, economic, and 
environmental effects) were studied within the assessment [1]. Technology assessment was defined as ǲthe systematic study of the effects on society, that may occur when a technology is 
introduced, extended, or modified, with emphasis on the impacts that are unintended, indirect, or delayedǳ [2]. 
Healthcare technologies were among the topics of early TAs [3]. Technologies that evoke 
social, ethical, legal, and political concerns have been the most assessed from the beginning of 
HTA until now (e.g., contraceptives, life-sustaining technologies for critically or terminally 
patients, artificial organs, organ transplantation) [4]. Even though HTA application is currently 
wider than in the past, the majority of technologies currently assessed seem still to be the ones 
with the same aforementioned characteristics (e.g., genetic testing or therapy, ultrasonography 
for fetal sex selection, stem cell research). 
The original intent of TA to be as much comprehensive as possible, was rapidly neglected towards more rapid and easier reports ȋe.g., ǲhorizon scanningǳ, ǲrapid (TAǳȌ or focusing only 
on certain sets of impacts or concerns (defined ǲdomainsǳ by the European network for Health 
Technology Assessment, and called ǲdimensionsǳ in the present documentȌ. ǲPartial TAǳ has 
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been indeed often preferred to decision makers in circumstances where selected impacts are of 
particular interest or because of resource constraints [5]. 
1.1.2. Health Technology 
Many different definitions of health technology are available in the literature. For example, 
health technology is defined by [6] as drugs, devices, and medical and surgical procedures used 
in the prevention, diagnosis, treatment, and rehabilitation of disease. It is also defined by the 
World Health Organization (WHO) as the ǲapplication of organized knowledge and skills in the 
form of devices, medicines, vaccines, procedures and systems developed to solve a health problem and improve quality of livesǳ, comprising also organizational systems used in health 
care. Taxonomies of technology and its attribute have been proposed, often dividing it by 
discipline or by a single attribute. Health Technologies are frequently grouped in accordance to 
their physical nature (e.g., drugs, biologics, devices, equipment and supplies), purpose (e.g., 
prevention, screening, diagnosis, treatment, rehabilitation, palliation) and stage of diffusion (e.g., 
future, experimental, investigational, established, obsolete). However, differences within each 
group are not always clearly delineated and not all technologies fall neatly into single categories. 
A comprehensive, even though not exhaustive, definition of technology is provided by [7] 
and reported in Table 1. This thesis focuses on ǲcommonǳ technologies ȋe.g., medical devices), but it also addresses 
hospital services that may be considered technologies whereas they are referred to hospital 
policy and strategy as alternatives for strategic directions, for deciding which kind of hospital 
service is convenient to implement. Scientific studies stating that ǲhospital serviceǳ follows under the definition of ǲtechnologyǳ within (ealth Technology Assessment are not available at 
the state-of-the-art. However, hospital services have been studied through HTA, considering it as important ǲhealth technology assetǳ [8]. 
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Categories Illustrative components (what it contains) 
Dominant perspective 
(what it does) 
Illustrative 
sources 
A. Technology as 
an artifact or 
instrument 
 ideas 
 instruments 
 machines 
 systems 
 devices 
 tools 
 products 
 processes 
 solutions 
 operationality 
 instrumentality 
 functionality 
 enabling qualities 
[9] 
[10] 
[11] 
B. Technology as 
a process 
 stage and activities  creates the means of 
developing, producing 
and delivering products 
and services 
 creates new realities 
[12] 
[13] 
[14] 
[15] 
 research 
 testing 
 prototyping 
 manufacturing 
 commercialization 
 experimentation 
 development 
 design 
 engineering 
 marketing 
 transfer & exchange 
 simulation 
 outcomes and outputs 
 innovations  knowledge 
(publications, patents) 
C. Technology as 
knowledge and 
information 
 information 
 intelligence 
 techniques 
 methods 
 procedures 
 approaches 
 provides input to the 
generation, conduct & 
performance of economic 
& other activities & the 
means to do so 
[16] 
[17] 
[18] 
D. Technology as 
policy and 
strategy 
 alternative for strategic direction 
 limitations to strategic and policy decisions 
 defines, delineates, and 
sets boundaries to policy 
and strategy 
[19] 
E. Technology as 
organizational 
dimensions 
 core competencies 
 competitive edge 
 differentiates among 
organizations 
 provides the context for 
structure and processes 
[20] 
[21] 
Table 1 – Definitions of Technology: A Summary of Individual, Organizational and Socio-Economic Categories (from [7]) 
1.1.3. Health Technology Assessment 
In addition to the lack of a standardized definition of Health Technology, also Health 
Technology Assessment is not rigorously defined and scientific literature, as well as international 
societies and associations devoted to HTA, provides different definitions of HTA. For example, 
[22] states that assessment of a medical technology is ǲany process of examining and reporting 
properties of a medical technology used in health care, such as safety, efficacy, feasibility, and 
indications for use, cost, and cost-effectiveness, as well as social, economic, and ethical consequences, whether intended or unintendedǳ; (ealth Technology Assessment )nternational 
(HTAi) society reports that ǲ(TA is a field of scientific research to inform policy and clinical 
decision making around the introduction and diffusion of health technologies. It is a 
multidisciplinary field that addresses the health impacts of technology, considering its specific 
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healthcare context as well as available alternatives. Contextual factors addressed by HTA include 
economic, organizational, social, and ethical impacts. The scope and methods of HTA may be adapted to respond to the policy needs of a particular health systemǳ; the European network for 
Health Technology Assessment (EUnetHTAȌ states that ǲ(TA is multidisciplinary process that 
summarises information about the medical, social, economic and ethical issues related to the use 
of a health technology in a systematic, transparent, unbiased, robust manner. Its aim is to inform 
the formulation of safe, effective, health policies that are patient focused and seek to achieve best 
value. Despite its policy goals, HTA must always be firmly rooted in research and the scientific methodǳ. 
It is interesting noticing that most of the definitions of HTA, such as the ones previously 
reported, are strongly heterogeneous and include different kind of dimensions of analysis, different characteristics, and different meanings of ǲhealth technologiesǳ. Particularly, clinical 
aspect is the most frequently included aspect, followed by economic aspect [23]. However, it is 
unclear how, in HTA bodies around the world, various criteria are taken into account in each 
decision [24]. On the other hand, all references seem to be in accordance to include multidisciplinary teams, and to let (TA serve to ǲtranslateǳ scientific findings and approach into 
practical and intelligible information to be used from decision makers. Hence, one of the main 
challenges of HTA is to provide easy-to-use tools to decision makers through scientific and 
rigorous methods. 
Depending upon the topic and scope of the assessment, multidisciplinary teams can be 
composed by a broad variety of professionals (e.g., physicians, nurses, managers of healthcare 
institute, laboratory technicians, patients, epidemiologists, economics, lawyers, 
clinical/biomedical engineers). Particularly, clinical engineers play a crucial role in the 
assessment, since they own transversal skills enabling them to interact with all the professionals 
involved. 
Even if there is a great variation in the scope, selection of methods and level of detail in the 
practice of HTA, most HTA activity involves the following steps [3]: 
1. Identify assessment topics 
2. Specify the assessment problem or questions 
3. Retrieve available relevant evidence 
4. Generate or collect new evidence (as appropriate) 
5. Appraise/interpret quality of evidence 
6. Integrate/synthesize evidence 
7. Formulate findings and recommendations 
8. Disseminate findings and recommendations 
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Anyhow, not all assessment programs conduct all of these steps, and they are not 
necessarily conducted in a linear manner [3]. 
Often, assessment topics are determined by the mission or purpose of an organization. 
Generally, technologies are assessed on a reactive basis (referring to technologies already in the 
market), under request of national and regional health plans, as well as other third-party payers, 
in order to decide whether or not adopting a particular technology. However, ǲhorizon scanningǳ 
has been developed in order to provide prompt information about new and emerging health care 
interventions [25], [26], [27], [28]. Horizon scanning is presented in Paragraph 2.2. 
Regarding when to conduct an assessment, there is not a ǲrightǳ timing to perform HTA and, 
as [29] stated, ǲ)tǯs always too early until, unfortunately, itǯs suddenly too late!ǳ. )n this context, 
one of the main issues is related to the fast development and progress of technologies: by the 
time a HTA is conducted, reviewed, and disseminated, its findings may be outdated. 
Methods used for performing HTA can be divided into two groups: primary data methods 
involve collection of original data (e.g., clinical trials, observational studies); integrative methods 
(or secondary or synthesis methods) involve combining data or information from existing 
sources, including primary data studies [3]. Primary data method ranges from more scientifically 
rigorous approach for determining the causal effect of health technology (e.g., Randomized 
Controlled Trials – RCTs), to less rigorous ones, such as case series. However, methods 
frequently used for performing HTA are integrative methods, particularly systematic reviews 
and meta-analysis, based on primary data studies (e.g., journal articles, epidemiological data 
sets). More generally, methods used to combine or integrate data from primary sources include 
systematic literature review, meta-analysis, modeling (e.g., decision trees, state-transition 
models), group judgment, unstructured literature review, expert opinion. 
Specifically, modeling is used to represent (or simulate) health care processes or decisions 
and their impacts under conditions of uncertainty, such as in the absence of a wide amount of 
data or when it is not possible to collect data on all potential conditions, decisions, and outcomes 
of interest. Particularly, Multi-Criteria Decision Analysis (MCDA) is raising the attention of 
researchers and decision makers. Indeed, MCDA methods provide greater transparency and 
consistency in decision-making [24]. 
On the other hand, several tools are available for assessing different dimensions within HTA. 
For example, many economic analysis methods can be found in the literature, such as cost-of-
illness analysis; cost-minimization analysis; cost-effectiveness analysis (CEA), including cost-
utility analysis (CUA) and cost-consequence analysis; cost-benefit analysis (CBA); budget-impact 
analysis (BIA). 
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All the topics mentioned in the present chapter, that constitute the heterogeneity of health 
technologies and HTA, have been widely debated in the literature, letting raise two different 
positions: the first one asserts that health technology can be assessed in any meaningful sense at 
all, conceding reports to be treated as just one account among many, incommensurable accounts 
[30]; the second one [31] criticized this position as tantamount to ǲmethodological anarchyǳ, 
stating a more rigorous approach was necessary. Trying to answer this challenge, proposing a 
structured approach taking into account, at the same time, the peculiarities of each technology to 
be assessed, has been one of the purposes of the present work. 
Moreover, as reported by [3], some of the main barriers of HTA can be listed as follow: 
 Technological imperative: in wealthy countries, there is often the expectation that 
new is better, and the inclination to use a technology that has potential for some 
benefit, however marginal or even poorly substantiated [32]; 
 Limited resources for HTA: resources allocated for HTA are often drastically small 
compared to national health care spending; 
 Insufficient primary data: primary studies and other data are not always available, 
especially at a local or regional level, whereas peculiarities of each country is 
essential for assessing technologies to be adopted; 
 Timing misalignment: HTA reports are often time-consuming and results of the 
analysis may be available too late compared to the real need; 
 Marketing and promotion: provided by health care product companies with the 
unique purpose of selling, they can weight against HTA findings; 
 Political actions: they can circumvent (TA, through ǲlobbyingǳ or ǲpressure groupsǳ. 
This occur, for example, when political (regional, national or international) directives 
or programs push and press healthcare institutions as well as citizen to adopt certain 
technologies, in contrast to findings based on available evidences, or in the absence of 
rigorous evidences; 
 Implementation barriers: there are several barriers to implementing HTA, such as 
complex and technical formats of HTA reports, absence of real-world applications, 
and narrow focus [33]. Moreover, HTA recommendations may be difficult to implement due to cliniciansǯ and other providersǯ reluctance to change long-standing 
practice routines. Furthermore, lack of versatility of many HTA reports does not 
allow to implement solutions in certain cases due to practical external constraints, 
such as particular environment, professional training, or other resources that are 
unavailable in a particular facility. 
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)n recent years, a new approach of (TA, called ǲrapid (TAǳ is emerging due to decision 
makers increasing requests for faster responses. Compared to full HTAs, rapid HTAs have 
limiting scope to fewer types of impact, focus searches on fewer bibliographic databases, rely on 
fewer types of studies, use shorter and more qualitative syntheses with categorization of results 
without meta-analysis [34]. 
Another interesting trend is the decentralization of HTA. Indeed, despite the initial approach 
of conducing HTA by government agencies and other national- or regional-level organization, 
HTA evolved into a more decentralized function [35], [36], taking into account peculiarities of 
each specific context, and considering different perspectives. 
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1.2. MCDA 
The use of Multi-Criteria Decision Analysis (MCDA) in health care context represents one of 
the most frequently used decision-making frameworks [37] [38], providing a sound and rigorous 
approach for decision making in health care [39]. Indeed, MCDA is widening used in the 
healthcare context with a statistically significant and steady increase over the years as reported 
by [40] (Figure 1). 
 
Figure 1 – Publication pattern of MCDA applications in health over the years 1960-2011 (from [40]) 
MCDA can be described as a tool based on a set of qualitative and quantitative data that 
simultaneously take into account multiple and often conflicting factors [41]. It can be defined as ǲa set of methods and approaches to aid decision-makers, where decisions are based on more 
than one criterion, which make explicit the impact on the decision of all the criteria applied and the relative importance attached to themǳ [24]. Some types of MCDAs are based on sophisticated 
algorithms to suggest optimal choice, while others just aid to provide some structure to the 
deliberative process. It is important underlying that MCDA represents only a support to decision 
making, requiring anyway degrees of judgment by decision makers. 
In the previous paragraphs, the importance of including different dimensions (and, 
consequently, criteria) for assessing a technology was underlined. MCDA allows to involve 
multiple criteria and multiple stakeholders, through a systematic process that clarifies what is being taken into account ȋthe ǲcriteriaǳȌ, how each of those criteria is to be measured, and how much importance ȋǲweightǳȌ to put on each from decision makers perspectives. 
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A wide range of MCDA tools are available in the literature, used in different contexts (e.g., 
business, management, healthcare). Some of Multi-Criteria Decision Making (MCDM) methods, 
many of which implemented by specialized decision-making software, include: Aggregated 
Indices Randomization Method (AIRM); Analytic Hierarchy Process (AHP); Analytic Network 
Process (ANP); Data Envelopment Analysis (DEA); Measuring Attractiveness by a Categorical 
Based Evaluation Technique (MACBETH); Multi-Attribute Utility Theory (MAUT); Multi-Attribute 
Value Theory (MAVT); Nonstructural Fuzzy Decision Support System (NSFDSS); Potentially All 
Pairwise RanKings of all possible Alternatives (PAPRIKA); PROMETHEE (Outranking); Simple 
Multi-Attribute Rating Technique (SMART) [42]. 
 A brief description of some MCDMs and related software is provided by [43] and reported 
in Table 2.  
 
Program/Developer/Price Description 
1000Minds (1000Minds Ltd.) 
Free for academic purpose, other 
negotiable 
Helps with decision-making, prioritization and discovering stakeholder 
preferences. Depending on application, can also help in considering 
alternatives and allocation of budget or other scarce resources. As well as 
stand-alone decision tools, offers customizable processes to include potentially 
up to 1000s of participants in a variety of group decision-making activities. 
Applies patented PAPRIKA (Potentially All Pairwise RanKings of all possible 
Alternatives) method. Web-based software with a tab-based interface. 
Preferences with numerous pairwise questions on criteria. Various ways to 
analyze results. Sharing results on the net and possibility for voting or surveys. 
Analytica (Lumina Decision System, 
Inc.) 
Professional version $995 
Helps in building business models or policy analysis. Has intuitive influence 
diagrams for creating models and allows communicating clearly with 
colleagues and clients. Its Intelligent Arrays allows creating and managing 
multidimensional tables with an ease and reliability and efficient Monte Carlo 
allows quickly evaluating risk and uncertainty and finding out what variables 
really matter and why. Object-oriented visual interface, with which one can 
implement practically any method. Various graph-building. Pre-defined 
modules available, for example, for MAUT, optimization, and risk analysis. 
Various distributions available. 
Criterium Decision Plus 3.0 
(InfoHarvest) $895 
Can be used for managing the entire decision process. Applying a structured 
methodology to decision making helps in making precise, thoughtful and 
completely supportable decisions. Includes Direct Tradeoffs, larger models, 
powerful graphics and extensive options for supporting insightful, persuasive 
decision making faster and for more complex models than ever. Basic MAVT 
software with AHP functionality 
Decide IT (Preference) 
Free for academic use. 
Commercial license: $1900 + 
$900/year 
Enables to carry out reliable risk and decision analyses. Includes state-of-the-
art decision methodologies and mathematical analysis in an efficient and user 
friendly software. Comes with an easy-to-use graphical user interface in which 
decision trees together with criteria hierarchies constitute the main schematic 
overview of the decision architecture. Such models are very useful in cases of 
complex decisions, as they provide the decision maker and decision analyst 
with a graphical presentation of the decision situation and show the internal 
relations between options, objectives and uncertain parameters. MCDA 
 
 
MCDA   CHAPTER 1 
 
 
 
15 
 
Program/Developer/Price Description 
software providing both value and decision tree approaches. Uses intervals 
and inequality relations in weighting. Probabilistic analysis of imprecise 
results 
Decision Tools (Palisade 
Corporation) 
Depends on the license 
(Stand-alone single-user license: 
£2000) 
Integrated set of programs for risk analysis and decision making under 
uncertainty that runs in Microsoft Excel. Includes @RISK for Monte Carlo 
simulation, PrecisionTree for Decision Trees, and TopRank for ǲWhat-)fǳ 
sensitivity analysis. In addition, comes with StatTools for statistical analysis 
and forecasting, NeuralTools for predictive neural networks and Evolver and 
RISKOptimizer for optimization. All programs integrate completely with 
Microsoft Excel for ease of use and maximum flexibility 
GMAA (Universidad Politécnica de 
Madrid) 
Available free of charge for 
academic purpose 
DSS based on an additive multi-attribute utility model that accounts for 
incomplete information concerning the inputs. The system is intended to allay 
many of the operational difficulties involved in the DA cycle, which can be 
divided into four steps: structuring the problems; identifying the feasible 
alternatives, their impact and uncertainty; quantifying preferences; evaluating 
strategies and performing Sensitivity Analysis. MAUT software with a 
possibility to use intervals to model imprecision 
Logical Decisions (Logical 
Decisions) 
1 installation: $895 
Allows evaluating choices by considering many variables at once, separating 
facts from value judgments and explaining choices to others. Uses techniques 
from the field of decision analysis to help in making more effective decisions. 
Provides a variety of methods for assessing attribute weights and has many 
results displays. Basic MAVT software with AHP functionality 
M-MACBETH (Bana Consulting Lda) 
Free demo available, academic 
license $175, professional $1750 
Uses interactive approach that requires only qualitative judgments about 
differences to help a decision maker or a decision-advising group quantify the 
relative attractiveness of options. Employs an initial, interactive, questioning 
procedure for comparing two elements at a time, requesting only a qualitative 
preference judgment. As judgments are entered into program, it automatically 
verifies their consistency. A numerical scale is generated that is entirely consistent with all the decision makerǯs judgments. Through a similar process 
weights are generated for criteria. MAVT software that support Macbeth 
method, various graphical ways to assess the parameters 
TESLA (Quintessa) Software tool for supporting decision makers when faced with complex 
decision problems. Provides a means to break a decision down into a 
hierarchical structure, simplifying the problem and presenting it in such a way 
that information can be easily gathered and categorized. Software with 
decision tree approach and evidence based updating of probabilities 
V.I.S.A. Decisions (SIMUL8 
Corporation Ltd) 
Standard version (Includes 
standalone application and web-
based version) $495 
Created for decisions with multiple, tough to balance factors; where no option 
matches all of the criteria perfectly; or for decisions where more than one 
person has a say in how the decision is made. It allows weighing up all the 
factors using a considered and sound process and documents how decision 
was made and why it was the right outcome for future reference. Basic MAVT 
software 
Table 2 – Description of some Multi-Criteria Decision Methods, related software and other information (from [43]) 
The comparative analysis of multi-criteria decision support system published by [43], 
reported also the classification of the 10 different tools presented in Table 2, considering 
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different features characterizing each system. 1000Minds, DecideIT, and GMAA results to be free 
of charge for academic purposes. Even though 1000Minds was rated at the 5th position, it is the 
only one that runs on web browser and not on proprietary platform (Windows), and it is the 
easiest to use among the others, requiring low level of expertise. These characteristics are very 
important for decision makers because they often do not possess technical skills, needing user-
friendly tools, and they are frequently subjected to economic constraints. 
For these reasons, PAPRIKA tool will be described in detail. 
1.2.1. PAPRIKA 
PAPRIKA is a method developed in 2008 by [44]. It specifically addresses additive multi-attribute value models with performance categories ȋǲvalue modelsǳȌ, where each criterion is 
demarcated into mutually exclusive categories. In the most traditional approaches, value score of 
each criterion is assigned using either identical rating scales (e.g., 1-100) or single-criterion 
value functions; normalized criterion weights are used to represent the relative importance of 
the criteria. Most of the available tools provide a ratio or interval scale measurements of 
decision-makersǯ preferences. PAPRIKA is based on the same principle of weighting criteria, but 
it implements a different method, without interval scale measurements provided to decision-
makers, but ranking potentially all hypothetically possible alternatives in a pool that changes 
over time. Particularly, PAPRIKA let decision-maker pairwise rank potentially all ǲundominated 
pairsǳ1 of all possible alternatives represented by the value model being scored. Conversely, the alternatives in ǲdominated pairǳ are inherently pairwise ranked. The number of undominated 
pairs to be explicitly ranked is minimized by PAPRIKA through identification and elimination of 
all pairs implicitly ranked, via the transitivity property of additive value models: having called ǲdegreeǳ the number of criteria included in the study, the algorithm starts comparing 
alternatives at 2nd-degree (pairwise comparisons of two alternatives, considering 2 criteria 
each) up to the highest degree (i.e., total number of criteria included in the study). For example, 
ranked 2nd-degree pairs implies ranking of some of 3rd-degree pairs, etc. From the inequalities 
(decision maker prefers one alternative among two during pairwise comparisons) or equalities ȋdecision maker doesnǯt express a preference, stating both the alternatives are equal), point 
values are obtained via linear programming. Hence, PAPRIKA automatically avoids potential 
inconsistencies in the decision-makerǯs rankings as well as redundancies. The flowchart of the 
PAPRIKA method is presented in Figure 2. 
                                                          
1
 ǲUndominated pairǳ is a pair of alternatives where one is characterized by a higher ranked category for at 
least one criterion and a lower category for at least one other criterion than the other alternative. 
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Figure 2 – Flow chart of the PAPRIKA method (from [44]) 
The method proposed by PAPRIKA implies two computationally processes for (1) 
identifying all unique undominated pairs, and (2) identifying all implicitly ranked pairs.  
The number of undominated pairs (N) and the number of unique undominated pairs (U) of 
degree ݖ ሺݖ = ʹ, ͵, … , ݊ሻ are given by the Equation 1 and Equation 2 respectively. 
Equation 1 ܰሺ݊, ݕ, ݖሻ = ܥ௭௡ ሺʹ௭−ଵ − ͳሻሺ ܥଶ௬ ሻ௭ݕ௡−௭ 
Equation 2 ܷሺ݊, ݕ, ݖሻ = ܥ௭௡ ሺʹ௭−ଵ − ͳሻሺ ܥଶ௬ ሻ௭ 
Start
Set Degree = 2
Identify undominated pairs for 
Degree, and for Degree > 2 discard 
pairs implicitly ranked as 
corollaries of the explicitly ranked 
pairs
Are there any 
erstwhile 
undominated pairs 
for Degree that are 
not ranked?
Present an undominated pair for 
the decision-maker to rank
Identify (and discard) all 
undominated pairs for Degree 
implicitly ranked as corollaries of 
the explicitly ranked pair(s)
Increment 
Degree by 1
Is Degree > number 
of criteria in the 
model?
Solve the explicitly ranked pairs for 
the point values
Finish
No
Yes Yes
No
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where ܥ௭௡  is the number of combinations of the ݊ criteria taken ݖ at-a-time, and ܥଶ௬  is the 
number of combinations of the ݕ categories for each criterion taken two at-a-time. 
After a given pair has been ranked by decision-makers, implicitly ranked pairs are 
identified, proposing hypothetical ranking to decision makers, until they are explicitly ranked by 
decision makers (for more details, see [44]).  
 
The number of pairwise comparisons to be answered by decision makers depends by their 
answers and preferences, that are linked to the ability of the algorithm to rank all undominated 
pairwise comparisons. 
PAPRIKA method results to be easy-to-use and more natural from decision makersǯ 
perspective, compared to the traditional methods (e.g., SMART) [44]. Moreover, the real-world 
application suggested that decision makers are able to rank comfortably more than 50 and up to 
at least 100 pairs, and in a short period. 
Hence, this method resulted to be the most appropriate for the aims of the present work, in 
order to combine scientific approach with real practical needs of decision makers. 
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Chapter 2 
Medical devices assessment 
In Europe, the number of medical technologies patented each year has doubled the number 
of drugs and biotechnologies. In 2014, medical technologies were 1st for IP applications. This 
suggests that in the next years, thousands of new medical devices will be available to be 
introduced into the market, causing a significant shift in healthcare costs from drugs to devices. 
Today, the unique technologies assessed through standardized methods and tools are drugs 
and patient-oriented procedures. Indeed, several methods have been developed in the past for 
drugs, which are deeply different from medical devices or other technologies. Indeed, differently 
from drugs, medical devices require significant maintenance or installation costs; price is more 
dynamic; medical device efficacy is user dependent, since outcomes often depend on training and 
experience of the operator (e.g., the skill of surgeons using minimally invasive surgery can make 
the difference) [45]. Last, but even more important, medical devices can be prognostic, 
therapeutic, diagnostic or for rehabilitation purposes, while drugs are only therapeutic. The 
adopted methodological frameworks for HTA currently available do not fully encounter the 
challenges rising from technologies as medical devices [46], causing the necessity to adapt the 
tool to each technology. 
In this chapter two different medical devices are assessed, through two different case 
studies: the first research study concerns the identification of the best medical device for 
thyroidectomy and it was performed through a more typical HTA approach based on systematic 
review of the available literature, considering the most important dimensions for a 
comprehensive assessment; the second one [47], [48] represents a preliminary study for 
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assessing an innovative technology not yet in the market. Particularly, the main contribution 
given in the latter was the identification of the major needs at the state-of-the-art, of the 
available solutions, of the most important features to be developed for the innovative 
technology, that were summarized into the overall preliminary assessment. 
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2.1 Hospital-Based HTA of vessel sealing in thyroidectomy 
As briefly introduced in the first chapter, the assessment of technologies already in the 
market often differs from technologies not yet in the market. Indeed, for the first kind of 
technologies, more data are usually available in the literature and comparison of the different 
dimensions (e.g., clinical effects) among different technologies results to be easier. This 
paragraph takes into account the more traditional HTA approach, as presented in the first 
chapter, performed on a medical device used for surgical operations. 
Particularly, the study aimed to assess the traditional hemostatic technique (i.e., classic 
suture ligation) and vessel sealing systems (i.e., disposable bipolar vessel sealer LigaSure, 
reusable bipolar vessel sealer BiClamp, and disposable ultrasonic coagulating shear Harmonic 
Focus) in thyroidectomy, in order to identify the best technology to be used in an hospital that 
served as case study (ǲG. Pascaleǳ hospital in Naples, Italy). Hospital-Based Health Technology 
Assessment was conducted in order to identify an effective, appropriate and economically 
sustainable technology as alternative to traditional hemostatic technique in thyroidectomy, at 
the G. Pascale hospital, where currently an average of 100 total thyroidectomies are performed 
each year, using the standard technique. 
2.1.1 Introduction 
After the introduction by Kocher and Billroth of a surgical technique (1872) that reduced 
mortality from 75% to 0.5%, the thyroidectomy has become one of the most frequently used 
surgical procedures in endocrinal surgery [49]. The majority of pathologies related to thyroid, 
especially in case of neoplasia, are treated through a total thyroidectomy, in order to ensure the 
removal of the whole site and prevent possible relapses. 
In thyroidectomy, as well as in other kind of surgical procedures, hemostasis is considered 
crucial, and the possible consequences of intra-surgeries bleeding (e.g., hematomas, infections) 
have to be reduced and prevented. 
The traditional hemostatic technique for achieving hemostasis during a surgical procedure 
consists of closing vessels through tie ligation. The mechanism associated with this technique is 
vessels occlusion through natural coagulation and aggregation of fibrin. Even though this method 
is still in use, nowadays other new methods are usually preferred. 
Indeed, in the last decades, besides mechanical hemostatic techniques (e.g., sutures, clips), technologies based on coagulation techniques, using radiofrequencies ȋǲRFǳȌ or ultrasound 
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energy, have been developed. These methods allow managing both dissection and hemostasis 
during surgical procedures. 
Particularly, the vessel sealing is a hemostatic technique performed by a medical device in 
which collagen and elastin of vessel wall are fused and a permanent seal is formed. 
2.1.2 Methods 
2.1.2.1 Analyzed medical devices 
Medical devices available on the market were firstly identified. Specifically, medical devices 
for vessel sealing currently in use can be divided into disposable and reusable. Within the first 
category, we included the ǲForceTriad™ radiofrequency energy platform + LigaSure™ Small Jaw 
disposable handpieceǳ from Covidien LLC ȋcalled ǲDRFǳ as Disposable RF system in the present 
studyȌ and the ǲGenerator GENͳͳ + Ultrasonic shear (armonic Focus® from Ethicon Endo 
Surgery LLC (called ǲUSǳ as Ultrasound system in the present study). Regarding the reusable devices, we included the ǲV)O ͵ͲͲD radiofrequency generator + BiClamp® reusable handpieceǳ 
from Erbe Elektromedizin, GmbH (called ǲRRFǳ as Reusable RF system in the present study). We 
excluded the hybrid system ǲThunderbeatǳ from Olympus Medical System Systems Corp, and ǲAF 
Maxium radiofrequency generator + MarClump Cut IQ instrumentǳ from  Gebruder Martin Gmbh 
&Co. Kg, ǲARC radiofrequency generator + TissueSeal Plus instrumentǳ from Bowa-Electronic 
Gmbh & Co. Kg, and ǲSonoSurg ultrasonic generator + dedicated reusable instrumentsǳ from 
Olympus Medical System Systems Corp, since no clinical studies of their use in thyroidectomy 
are available in the literature.  Particularly, regarding the above mentioned techniques included 
in the study, the handpiece of DRF system, i.e., disposable hand-held dissector based on 
radiofrequency energies, integrates cutting mechanism and it is designed for the use in open 
procedures. The handpiece of ultrasound system, hand-held ultrasonic dissector in titanium, 
provides also cutting mechanisms. The handpiece of RRF system delivers radiofrequency current 
and the hand-held BiClamp 150C is specifically designed for the use in open procedures in thyroidectomy. )t doesnǯt provide cutting mechanisms.  
Before performing the technology assessment, we defined our research question through 
P.I.C.O. (Population, Intervention, Comparison, Outcomes) method identifying for each 
dimension the following: 
 Population: Patients under total thyroidectomy surgical operation; 
 Intervention: ultrasonic/radiofrequency, disposable/reusable vessel sealing systems 
in thyroidectomy; 
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 Comparison: traditional hemostatic technique VS vessel sealing systems; 
 Outcomes: reduction of surgery duration, hospital stay, intra-operative bleeding, 
incidence of post-operative complications (indicators generally used for assessing 
the effectiveness by the literature) and costs. 
Hence, the research question is: ǲCan the use of vessel sealing systems in thyroidectomy reduce the abovementioned outcomes compared to the traditional hemostatic technique?ǳ 
2.1.2.2 Data 
We conducted a systematic review of the literature, including electronic databases (Pubmed 
and Cochrane Library) as well as gray literature, thesis and medical devices manufacturer 
reports. 
For searching into electronic databases, we used a combination of keywords related to 
thyroidectomy and the three aforementioned technologies, as follow: 
 ("thyroidectomy"[MeSH Terms] OR "thyroidectomy"[All Fields]) AND sealing[All Fields], 
that resulted in 61 papers (including 18 clinical trials and 36 comparative papers) in 
PubMed database, and 29 papers (including 24 clinical trials) in Cochrane Library; 
 (LigaSure[All Fields] AND ("thyroidectomy"[MeSH Terms] OR "thyroidectomy"[All 
Fields])), that resulted in 65 papers (including 20 clinical trials and 29 comparative 
papers) in PubMed database, and 27 (including 22 clinical trial) in Cochrane Library; 
 (BiClamp[All Fields] AND ("thyroidectomy"[MeSH Terms] OR "thyroidectomy"[All 
Fields])), that resulted in 3 papers in PubMed database, and no results in Cochrane 
Library; 
 (Harmonic Focus[All Fields] AND ("thyroidectomy"[MeSH Terms] OR 
"thyroidectomy"[All Fields])), that resulted in 29 papers (including 13 clinical trials 
and 13 comparative papers) in PubMed database, and 18 (including 17 clinical trials) 
in Cochrane Library. 
Moreover, other sources (i.e., systematic reviews and meta-analysis) were considered and 
studied. 
A total of 55 different papers was selected and included in our study (Table 3), after having 
applied the following criteria (with no date of publication restrictions): 
 Studies conducted on humans (studies involving animals were excluded); 
 Papers in English and Italian languages; 
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 Trials using at least one of the following hemostatic techniques: traditional 
hemostatic technique, ultrasonic or radiofrequency, disposable or reusable vessel 
sealing systems. 
 
Authors 
Date of 
publication 
Instrument Control 
Number of 
patients 
Type of 
thyroidectomy 
Design of 
the study 
Oussoultzoglou et 
al. [50] 
2008 RF reusable RF disposable 46 vs 40 Total No RCT 
Pniak et al. [51] 2014 RF reusable 
Standard 
method 
679 vs 263 
Total and 
partial 
No RCT 
Manouras et al. [52] 2005 
RF 
disposable 
Standard 
method 
94 vs 90 Total RCT 
Manouras et al. [53] 2008 
RF 
disposable 
vs 
Ultrasuoni 
Standard 
method 
148 vs 144 
vs 90 
Total No RCT 
Teksoz et al. [54] 2013 
RF 
disposable 
Ultrasound 126 vs 119 Total RCT 
Chang et al. [55] 2011 
RF 
disposable + 
Ultrasound 
Standard 
method 
1163 vs 
722 
Total No RCT 
Shen et al. [56] 2005 
RF 
disposable 
Standard 
method 
89 vs 62 
Total and 
partial 
No RCT 
Youssef et al. [57] 2008 
RF 
disposable 
Standard 
method 
15 vs 15 
Total and 
partial 
No RCT 
Lepner et al. [58] 2007 
RF 
disposable 
Standard 
method 
204 vs 199 
Total and 
partial 
No RCT 
Petrakis et al. [59] 2004 
RF 
disposable 
Standard 
method 
270 vs 247 Total No RCT 
Lachanas et al. [60] 2005 
RF 
disposable 
 72 Total No RCT 
Cordòn et al. [61] 2005 Ultrasound Standard 
method 
7 vs 12 
Total and 
partial 
RCT 
Ortega et al. [62] 2004 Ultrasound 
Standard 
method 
57 vs 57 
Total and 
partial 
RCT 
Sista et al. [63] 2012 Ultrasound 
Standard 
method 
119 vs 122 
Total and 
partial 
RCT 
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Authors 
Date of 
publication 
Instrument Control 
Number of 
patients 
Type of 
thyroidectomy 
Design of 
the study 
Calò et al. [64] 2012 Ultrasound 
Standard 
method 
681 vs 470 Total No RCT 
Gentileschi et al. 
[65] 
2011 Ultrasound 
Standard 
method 
43 vs 38 Total RCT 
Kiriakopoulos et al. 
[66] 
2004 
RF 
disposable 
Standard 
method 
40 vs 40 
Total and 
nearly total 
No RCT 
Materazzi et al. [67] 2013 Ultrasound 
Standard 
method 
141 vs 127 Total RCT 
Alesina et al. [68] 2010 RF reusable 
Standard 
method 
61 vs 62 
Total and 
partial 
No RCT 
Cipolla et al. [69] 2008 
RF 
disposable 
Standard 
method 
53 vs 52 Total No RCT 
Parmeggiani et al. 
[70] 
2005 
RF 
disposable 
Standard 
method 
70 vs 120 Total RCT 
Glover et al. [71] 2014 
RF 
disposable 
 399 Total No RCT 
Ruggiero et al. [72] 2014 Ultrasound RF disposable 200 vs 200 Total RCT 
Kuboki et al. [73] 2013 
RF 
disposable 
Standard 
method 
14-15 
Total and 
partial 
No RCT 
Saint Marc et al. 
[74] 
2007 
RF 
disposable 
Standard 
method 
100 vs 100 Total RCT 
Mourad et al. [75] 2011 Ultrasound 
Standard 
method 
34 vs 34 Total RCT 
Kwak et al. [76] 2014 Ultrasound RF disposable 130 vs 116 
Total and 
partial 
RCT 
Markogiannakis et 
al. [77] 
2011 Ultrasound  45 Total RCT 
Hahn et al. [78] 2015 Ultrasound 
Standard 
method 
82 vs 76 
Total and 
partial 
No RCT 
Pelizzo et al. [79] 2014 Ultrasound 
Standard 
method 
139 vs 147 Total No RCT 
Pardal [80] 2011 Ultrasound 
Standard 
method + RF 
disposable 
419 vs 468 Total No RCT 
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Authors 
Date of 
publication 
Instrument Control 
Number of 
patients 
Type of 
thyroidectomy 
Design of 
the study 
Bove et al. [81] 2012 
Ultrasound 
vs RF 
disposable 
Standard 
method 
80 vs 80 vs 
80 
Total No RCT 
He et al. [82] 2011 Ultrasound 
Standard 
method 
91 vs 54 Total RCT 
Duan et al. [83] 2013 Ultrasound 
Standard 
method 
389 vs 389 Total RCT 
Molnar et al. [84] 2014 
RF 
disposable 
Standard 
method 
10 vs 10 Total No RCT 
Cannizzaro et al. 
[85] 
2014 Ultrasound 
Standard 
method 
141 vs 124 Total RCT 
Kirdak et al. [86] 2005 
RF 
disposable 
Standard 
method 
8 vs 9 
Total and 
partial 
No RCT 
Barbaros et al. [87] 2006 
RF 
disposable 
Standard 
method 
50 vs 50 
Total and 
nearly total 
No RCT 
Coiro et al. [88] 2015 
RF 
disposable 
Standard 
method 
95 vs 95 Total RCT 
Zarebczan et al. [89] 2011 
RF 
disposable 
Ultrasound 87 vs 36 
Total and 
partial 
No RCT 
Sartori et al. [90] 2008 
RF 
disposable 
vs 
Ultrasound 
Standard 
method 
50 vs 50 vs 
50 
Total RCT 
Di Renzo et al. [91] 2010 
RF 
disposable 
vs 
Ultrasound 
Standard 
method 
31 vs 31 vs 
31 
Total RCT 
Konturek et al. [92] 2012 Ultrasound 
Standard 
method 
41 vs 41 Total RCT 
Hwang et al. [93] 2014 
RF 
disposable 
Ultrasound 64 vs 62 Total RCT 
Docimo et al. [94] 2012 Ultrasound 
Standard 
method 
100 vs 100 Total RCT 
Papavramidis et al. 
[95] 
2010 Ultrasound 
Standard 
method 
45 vs 45 Total RCT 
Marrazzo et al. [96] 2007 
RF 
disposable 
Standard 
method 
25 vs 25 Total RCT 
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Authors 
Date of 
publication 
Instrument Control 
Number of 
patients 
Type of 
thyroidectomy 
Design of 
the study 
Lombardi et al. [97] 2008 Ultrasound 
Standard 
method 
100 vs 100 Total RCT 
Frazzetta et al. [98] 2005 Ultrasound 
Standard 
method 
60 vs 60 Total RCT 
Ferri et al. [99] 2011 Ultrasound 
Standard 
method 
50 vs 50 Total RCT 
McNally et al. [100] 2009 
RF 
disposable 
Ultrasound 59 vs 15 Total No RCT 
Miccoli et al. [101] 2010 Ultrasound 
Standard 
method 
31 vs 31 Total RCT 
Pons et al. [102] 2009 
Ultrasound 
vs RF 
disposable 
Standard 
method 
20 vs 20 vs 
20 
Total RCT 
Hallgrimsson et al. 
[103] 
2008 Ultrasound 
Standard 
method 
27 vs 24 Total RCT 
Prgomet et al. [104] 2009 Ultrasound 
Standard 
method 
125 vs 37 
Total and 
partial 
No RCT 
Table 3 - List of publications selected and included in the HTA of vessel sealing in thyroidectomy. RCT stands for 
Randomized Controlled Trial 
2.1.2.3 Clinical effectiveness 
The criteria considered for assessing clinical effectiveness, as already introduced, are: 
1. Reduction of surgery duration; 
2. Reduction of hospital stay;  
3. Reduction of intra-operative bleeding; 
4. Reduction of incidence of post-operative complications (laryngeal nerves injuries and 
cases of hypocalcaemia). 
The first three indicators were calculated as weighed average within the included clinical 
trials, based on the number of subjects in the studies. The fourth indicator was calculated 
considering the incidence of total number of laryngeal nerves injuries and cases of hypocalcemia 
within the total examined population. 
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2.1.2.4 Economic Analysis 
Among the 55 studies selected for the effectiveness analysis, 12 papers focused on cost-to-
cost economic analysis (Chang et al. [55], Ortega et al. [62], Kiriakopoulos et al. [66], Alesina et al. 
[68], Cipolla et al. [69], Parmeggiani et al. [70], Saint Marc et al. [74], Konturek et al. [92], 
Lombardi et al. [97], Frazzetta et al. [98], Pons et al. [102], Hallgrimsson et al. [103]), with 
contrasting results. 
In order to assess the economic dimension, break-even point (BEP) analysis was performed. 
Particularly, costs are detailed in the following subsections, and there were divided into fixed 
costs (i.e., purchasing, maintenance, and installation) and variable costs (i.e., consumables, 
surgical team and operating room, hospital stay, and sterilization). Revenues were calculated considering the Unit Revenue of ͵,͵ͶͲ €, as foreseen by the Diagnosis-Related Group (DRG) 290 
in the Italian Healthcare System. 
The break-even points (x, in terms of number of surgeries) and the contribution margins 
(CM) were calculated as: 
 ݔ = ்௢௧௔௟ ��௫௘ௗ �௢௦௧௎௡�௧ ோ௘௩௘௡௨௘−௎௡�௧ ௏௔௥�௔௕௟௘ �௢௦௧ ; ܥܯ = ܷ݊�ݐ ܴ݁ݒ݁݊ݑ݁ − ܷ݊�ݐ ܸܽݎ�ܾ݈ܽ݁ ܥ݋ݏݐ 
 
The break-even revenue (BER) was found by multiplying the number of surgeries 
corresponding to the break-even points and the Unit Revenue. 
The margin of safety (MS) was calculated as: 
 ܯܵሺ%ሻ = �ݔ݌݁ܿݐ݁݀ ݎ݁ݒ݁݊ݑ݁ − ܤ�ܴ�ݔ݌݁ܿݐ݁݀ ݎ݁ݒ݁݊ݑ݁ ∗ ͳͲͲ 
All the specific information on costs, presented in this work, was collected through interviews to medical devices manufacturers and contracts at the ǲG. Pascaleǳ hospital. (ence, 
the cost analysis gathered both the literature and the specific constraints of the hospital and 
Italian regulations. 
Purchasing costs 
In Italy, the ForceTriad, VIO300D, and GEN11 generators are sold at an average value of Ͷͳ,͵ͷͺ €, ʹͷ,͸ʹͲ €, and ͵ʹ,ͻͶͲ € respectively ȋincluding taxesȌ. In accordance to the Italian 
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Legislative Decree n.118 (June, 23rd 2011), the cost is amortized over 5 years. Hence, the depreciation is of ͺ,ʹ͹ͳ.͸ € for the ForceTriad, ͷ,ͳʹͶ € for the V)O ͵ͲͲD, and ͸,ͷͺͺ € for the 
GEN11. 
Maintenance costs 
Considering the annual cost for medical electrical equipment maintenance approximately 
equal to the 10% of purchasing costs within a full-risk maintenance contract, we can estimate Ͷ,ͳ͵ͷ.ͺ € for the ForceTriad, ʹ,ͷ͸ʹ € for the V)O ͵ͲͲD, and ͵,ʹͻͶ € for the GEN11, within the 
maintenance costs. 
Installation costs 
Generators need just to be plugged, hence there are no costs related to installation. 
 
Therefore, the total amount of the fixed costs (sum of costs related to purchasing, 
maintenance and installation costs) of DRF, RRF and ultrasound systems, summarized as in 
Table 4, can be estimated as ͳʹ,ͶͲ͹.Ͷ €, ͹,͸ͺ͸.Ͳ €, and ͻ,ͺͺʹ.Ͳ € respectively. 
 
 
Purchasing cost 
(amortization 5 years) 
[€] Maintenance cost  [€] Installation cost [€] Total [€] 
RF disposable 8,271.6 4,135.8 0 12,407.4 
RF reusable 5,124.0 2,562.0 0 7,686.0 
Ultrasounds 6,588.0 3,294.0 0 9,882.0 
Table 4 – Total amount of the fixed costs (estimation) of DRF, RRF and ultrasounds systems 
Consumables 
In traditional hemostatic technique, approximately 10 silk cocoons for ligation of vessels are used. Each silk cocoon costs approximately ʹ € ȋincluding taxesȌ. So, the cost amount of consumables for each operation is ʹͲ €. 
Concerning the vessel sealing systems, the major costs are related to the handpiece itself: 
the hand-held disposable radiofrequency dissector is sold at Ͷͺ͵.ͺ € ȋincluding taxesȌ, the hand-
held reusable radiofrequency dissector, which is guaranteed for ͷͲ operations, is sold at ͳ,ͷʹͷ € ȋ͵Ͳ.ͷ € per operation, including taxesȌ, the hand-held disposable ultrasounds dissector is sold at ͸ʹʹ.ʹ € ȋincluding taxesȌ. 
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Operating team and operating room 
At the National Cancer Center G. Pascale, the thyroidectomy interventions involve 2 surgeons, ͳ anesthetist, and ͳ instrumentalist. Their costs per minute can be estimated as ͳ.͸͹ €, ͳ.͸͹ €, and Ͳ.͵Ͳ € respectively [98]. 
The cost of the operating room is Ͷ.͵Ͳ € per minute, including utilities, cleaning and laundry 
[98]. 
Hospital stay 
The average cost of one-day stay in the hospital is ͹ͳͲ €, as stated by the regional report of 
the Regional Agency for Health and Social Care. 
Sterilization costs 
Sterilization process is needed only for reusable handpieces. The related cost associated to a single procedure is ͳ.ʹͲ €, as reported by medical devices manufacturers enrolled at the 
National Cancer Center G. Pascale. 
2.1.3 Results 
Clinical effectiveness 
The three outcomes (reduction of surgery duration, reduction of hospital stay, reduction of 
intra-operative bleeding), presented in Table 5, were calculated as weighed average within the 
included clinical trials considering the number of subjects in the studies. 
 
 
1. Surgery duration 
Hemostatic 
technique 
Average surgery 
duration [mins] 
Confidence interval 
95% 
Number of 
studies 
Population 
Standard method 94.13 [94.10, 94.16] 40 3616 
RF disposable 81.35 [81.33, 81.37] 28 2230 
RF reusable 91.43 [91.36, 91.5] 3 786 
Ultrasounds 70.31 [70.29, 70.33] 30 3566 
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2.  Hospital stay 
Hemostatic 
technique 
Average hospital stay 
[days] 
Confidence interval 
95% 
Number of 
studies 
Population 
Standard method 2.69 [2.65, 2.73] 21 1998 
RF disposable 2.18 [2.13, 2.23] 15 1441 
RF reusable 3 [2.71, 3.29] 1 46 
Ultrasounds 2.8 [2.76, 2.84] 22 2566 
3. Intra-operative bleeding 
Hemostatic 
technique 
Average bleeding 
[ml] 
Confidence interval 
95% 
Number of 
studies 
Population 
Standard method 42.97 [42.89, 43.05] 7 557 
RF disposable 31.54 [31.46, 31.62] 6 639 
RF reusable N.A. N.A. N.A. N.A. 
Ultrasounds 31.46 [31.33, 31.59] 4 220 
Table 5 - Surgery duration, hospital stay and intra-operative bleeding calculated as weighed average within the included 
clinical trials, considering the number of subjects in each study 
The two outcomes related to reduction of incidence of post-operative complications, 
presented in Table 6, were calculated considering the total number of laryngeal nerves and 
parotid glands injuries among the total examined population. 
 
4. Incidence of post-operative complications 
Hemostatic 
technique 
Incidence of laryngeal nerves injuries 
[%] 
Number of studies Population 
Conventional 2.28 32 3521 
RF disposable 2.52 23 2183 
RF reusable N.A. 1 46 
Ultrasounds 1.64 28 3162 
Hemostatic 
technique 
Incidence of cases of hypocalcemia [%] Number of studies Population 
Conventional 13.55 32 3687 
RF disposable 9.84 21 2089 
RF reusable 6.5 1 46 
Ultrasounds 10.66 30 3376 
Table 6 - Incidence of post-operative complication calculated considering the total number of laryngeal nerves and 
parotid glands injuries among the total examined population 
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Economic Analysis 
The average of surgery duration (Table 5) and the variable costs ȋdetailed in the ǲMethodsǳ 
section) were used to estimate costs of operating team and operating room for each surgery, 
while the average of hospital stay was used to estimate costs of hospital stay for each surgery. Particularly, the cost related to the operating team results to be Ͷͻͻ.ͺ € for the traditional haemostatic technique; Ͷ͵ͳ.ͻ € for DRF; Ͷͺ͵.Ͷͻ € for RRF; ͵͹͵.͵ € for ultrasounds techniques. 
The cost related to the operating room results to be ͶͲͶ.͹ € for the traditional haemostatic technique; ͵Ͷͻ.ͺ € for DRF; ͵ͻ͵.ͳ € for RRF; ͵Ͳʹ.͵ € for ultrasounds techniques. Finally, the cost related to hospital stay results to be ͳ,ͻͲͻ.ͻ € for the traditional haemostatic technique; 1,547.8 € for DRF; ʹ,ͳ͵Ͳ.Ͳ € for RRF; ͳ,ͻͺͺ.Ͳ € for ultrasounds techniques. 
The total amount of the variable costs (sum of costs related to consumables, operating team, 
operating room, hospital stay and sterilization per surgery) was then estimated to be ʹ,ͺ͵Ͷ.ͷ € for the traditional haemostatic technique, ʹ,ͻͳ͵.Ͷ € for DRF, ͵,ͲͶͲ.͵ € for RRF and ͵,ʹͺͷ.ͻ € for 
ultrasounds techniques. The total amount of the variable costs is presented in Table 7. 
 
 
Consumables [€] Operating room [€] Operating team [€] Hospital stay [€] Sterilization [€] Total [€] 
Conventional 20 404.76 499.83 1,909.9 0 2,834.5 
RF disposable 583.81 349.81 431.97 1,547.8 0 2,913.4 
RF reusable 30.5 393.15 485.49 2,130.0 1.2 3,040.3 
Ultrasounds 622.2 302.33 373.35 1,988.0 0 3,285.9 
Table 7 – Total amount of the variable costs (estimation, per surgery) in the use of conventional technique, DRF, RRF and 
ultrasounds systems 
The break-even point analysis was performed only on the vessel sealing systems, since the 
conventional technique is unequivocally the most convenient in terms of costs, and through this 
technique the operating profit is reached right at the first surgery. 
Figure 3 shows the results of the BEP analysis for the three different techniques. Moreover, contribution margins resulted to be Ͷʹ͸.͸ͳ €, ʹͻͻ.͸͸ € and ͷͶ.ͳʹ € for RF 
disposable, RF reusable and Ultrasounds techniques respectively. 
Consequently, the break-even revenue ȋBERȌ is equal to ͻ͹,ͳʹ͹.ʹ€ for the disposable RF, ͺͷ,͸͹ͳ€ for the reusable RF, and ͸Ͳͻ,ͺͷͲ.͸ € for the ultrasounds technologies. 
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Figure 3 - Break even analysis results: disposable radiofrequency system (A), reusable radiofrequency system (B), 
ultrasound system (C). The number of surgeries is represented on the x-axis; the cost and income are represented on the y-
axis. 
As conclusion of the break-even point analysis, the margin of safety was calculated in order 
to understand how many surgeries can fall before the break-even point is reached for each 
technology. 
At the G. Pascale hospital, an average of 100 total thyroidectomies is performed each year, 
using the standard technique. 
29.08
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Since the use of RRF technique allows to save an average of 2.7 minutes each surgery 
compared to the standard technique (Table 5), three more thyroidectomies per year may be 
performed through this technique, compared to the traditional one. Consequently, the expected 
revenue can be calculated by multiplying the expected number of surgeries (103) and the DRGʹͻͲ ȋ͵,͵ͶͲ€Ȍ, resulting to be ͵ͶͶ,ͲʹͲ €. 
Similarly, through DRF and ultrasounds techniques, 13 and 24 minutes respectively can be 
saved for each surgery, allowing to perform 16 and 33 more surgeries per1 year. Thus, the expected revenues result to be ͵ͺ͹,ͶͶͲ € using the DRF technique and ͶͶͶ,ʹʹͲ € using the 
ultrasounds technique. 
Thus, the margins of safety for the three techniques result to be 74.93%, 75.1%, and -
37.28% for the DRF, RRF, and US respectively. 
Hence, the break-even point analysis shows that at the National Cancer Center G. Pascale at 
least 74.93% (using RF disposable) and 75.1% (using RF reusable) of total thyroidectomies must 
be guaranteed for not causing economic loss. Conversely, the ultrasounds technique is not 
economically sustainable for this hospital. 
The operating incomes per year, calculated as the difference between total incomes and total costs, result to be ͵͹,Ͳ͹ͻ.͵͸ € considering ͳͳ͸ surgeries with DRF technique, ʹ͵,ͳ͹ͺ.ͻͺ € considering ͳͲ͵ surgeries for the RRF technique, and loss equal to ʹ,͸ͺͶ.ͲͶ € considering 133 
surgeries for the ultrasounds technique. 
2.1.4 Discussion and conclusions 
The present study compared vessel sealing systems and traditional hemostatic technique in 
order to assess the best technology to be used at the National Cancer Center G. Pascale. The 
clinical effectiveness was conducted on 49 papers available in the literature, selected and 
included in our study. The economic perspective was assessed performing the break-even point 
analysis. 
Results of the HTA are summarized in Table 8. 
Regarding the effectiveness assessment, the results showed that vessel sealing systems can 
reduce surgery duration compared to the traditional technique currently in use at the National 
Cancer Center G. Pascale. Particularly, the use of DRF technique can reduce the thyroidectomy 
duration of 13 minutes (average), while the ultrasounds technique of 24 minutes (average) 
compared to the traditional technique. Due to the low number of clinical studies on RRF systems 
available in the literature, we cannot state that thyroidectomy duration reduction of 3 minutes 
(average among 3 studies) is significant. 
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Overall results 
 
Average 
surgery 
duration 
[mins] 
Average 
hospital 
stay 
[days] 
Average 
bleeding 
[ml] 
Incidence of 
laryngeal 
nerves injuries 
[%] 
Incidence of 
cases of 
hypocalcemia 
[%] 
BEP 
[n. of 
surgeries] 
Standard 
method 
94.13 2.69 42.97 2.28 13.55 ∀ 
RF disposable 81.35 2.18 31.54 2.52 9.84 29.08 
RF reusable 91.43 3 N.A. N.A. 6.5 25.65 
Ultrasounds 70.31 2.8 31.46 1.64 10.66 182.59 
Table 8 – Summary of HTA results 
Furthermore, the results of this study showed that vessel sealing systems can reduce intra-
operative bleeding and the incidence of hypocalcemia. On the other hand, no significant 
differences in terms of reduction of hospital stay and reduction of incidence of laryngeal nerves 
injuries were found.  
The economic assessment was made studying fixed and variable costs of the technologies, 
and the incomes through the DRG linked to thyroidectomy. The break-even points were found 
for the three vessel sealing systems. The RRF system is associated to the lowest BEP (25.65 
surgeries) among the techniques, followed by the DRF (29.08 surgeries). Even if they are more 
expensive compared to the traditional technique, the reduction of surgery duration may allow an 
increase of total surgeries per year. Indeed, both the DRF and the RRF techniques may guarantee 
cost recovery within 3 months. 
Conversely, the ultrasounds technique is demonstrated to be not sustainable from the 
economic perspective by the G. Pascale hospital. 
Moreover, based on the results of the literature, the RRF system is not often used in 
thyroidectomy, as also demonstrated by low number of the available clinical studies related to its 
use in thyroidectomy, while it is more often used for liver surgery and vaginal hysterectomy. The 
lack of a consistent number of clinical studies does not allow to assess the effectiveness of this 
technology in thyroidectomy. 
Conversely, DRF and ultrasound systems are largely used in thyroidectomy and they are 
demonstrated to be effective, as shown by the literature. However, among the two, only the 
disposable RF technology is economically sustainable for the hospital. Nevertheless, more 
generally, it is worth considering that costs related newest technologies and their consumables, 
are usually more expensive compared to the technologies already on the market, and this cost is 
expected to decrease over time. 
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In conclusion, according to our analysis, the DRF technology appears to be an effective and 
economically sustainable option for thyroidectomy at the National Cancer Center G. Pascale. The 
economic sustainability of the DRF technology is even more reinforced considering the lower 
average surgery duration compared to the other technologies: the saved time, as already stated,  
might allow to increase the availability of the operating rooms and, consequently, the number of 
surgeries. 
The methodology used in this work, essentially based on the identification of quantitative parameters from the literature for outcome evaluation and the successive costsǯ analysis, can be 
generalized and applied to different healthcare contexts, considering the specific constraints of 
the healthcare facility and the total number of surgical procedures, in order to identify the best 
technology to be adopted, in terms of outcomes and costs. However, a limitation of our study is 
the lack in the economic analysis of other direct costs related to the procedure, such as drugs, or 
other disposable medical device, that, for our purpose, may be considered negligible. In the 
future, once clinical data will be available in the literature, the study could be extended also to 
the excluded devices.  
 
 
ASSESSMENT AND DESIGN OF INNOVATIVE TECHNOLOGY: GAMYCARE CHAPTER 2 
 
 
 
37 
 
2.2 Assessment and design of innovative technology: GAMYCARE 
Technologies not already in the market follow different methods compared to the ones 
presented in the previous paragraph. This branch of (TA is called ǲ(orizon scanningǳ. (orizon 
scanning is intended to serve multiple purposes, including, for example, the following [3]: 
 Identify areas of technology change; 
 Identify variations in use of technology; 
 Forecast the health and economic impacts of technologies; 
 Anticipate potential social, ethical, or legal implications of technologies; 
 Enable health care providers, payers, and patients to plan for, adapt to, and manage technological change, including ǲrisingǳ/emerging technologies. 
Most horizon scanning programs generate rapidly completed, brief descriptions of new or 
emerging technologies and their potential impacts. As not much data is yet available in the 
literature, there are tradeoffs inherent in using early information that may be incomplete or 
unreliable. As a consequence, horizon scanning is often performed through ǲrapid reviewsǳ 
(briefly introduced in the first chapter). Indeed, rapid reviews were proposed by some authors 
[105] as an important intermediary step in the assessment of emerging technologies, to be 
followed by a more comprehensive assessment. More generally, horizon scanning was defined by 
the Organisation for Economic Co-operation and Development (OECD) as ǲa technique for 
detecting early sings of potentially important developments through systemic examination of 
potential threats and opportunities, with emphasis on new technology and its effects on the issue at handǳ and ǲit explores novel and unexpected issues as well as persistent problems and trendsǳ, whereas horizon scanning vision ǲis about exploring what the future might look like to understand uncertainties betterǳ ȋgov.ukȌ. 
A comparative study exploring differences in the complexity and findings of rapid and full 
reviews evaluated as 11 the minimum number of criteria to be addressed within a rapid review 
[106]. In the same study, it was proposed that a rapid HTA should focus on the study question by 
exactly defining the technology, outcomes, and study population to be examined. 
This approach (identification and design of the technology, focus on potential outcomes for 
the study population) was followed to perform the horizon scanning of a technology not yet on 
the market, designed in 2015 by the Clinical Engineering Group of the University of Trieste [47], 
[48], presented in the following paragraph. 
It is important to underline that HTA reports (including Horizon Scanning) should be 
performed by external professionals, in order to avoid bias due to conflict of interests. However, 
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the present study can be considered as an exercise for enriching the design of an innovative 
solution through the application of horizon scanning approach.   
Namely, an evidence-based approach was used, in order to study the state-of-the-art, 
underlying the current trend of emerging mobile technologies for healthcare. The review of the 
literature was not limited to the technological aspects, but it took into consideration also the 
best-practices and most advanced methods for supporting patients with chronic conditions. 
Moreover, in accordance with horizon scanning approach, the main issues of the solutions 
currently in use were identified. The output of this first step, allowed to select the most 
important features of an innovative technology, able to overcome the current issues and useful 
for patients. The most successful solutions already available in the market were then identified, 
filtered and compared with the proposed technology (approach similar to competitor analysis). 
Additionally, a preliminary assessment which involved 22 patients attending an outpatient 
Chronic Care clinic was performed, in order to assess the interest (declined in specific 
indicators) of the potential users.  
The overall study followed the approach of exploratory scanning, as defined by [107], 
focusing on the main current issues, and the impact of an innovative solution (within an 
emerging area of healthcare technologies). The performed assessment is close to a ǲbrief overviewǳ, defined as ǲin-depth but still brief overviewǳ [108] that, following its definition, 
includes background on the technology, information on how it works, clinical burden of the 
disease, current comparators, costs, and social, ethical, and legal concerns. However, not all the 
areas included in the definition were included in the study. The performed assessment is nearly 
close to horizon scanning template provided by [108], and it is structured as follow: 
1. Patient- and setting-related information: indications, specialty, patient numbers, setting 
for technology use, alternative or complementary technologies; 
2. Technology-related information: name, description, company or developer, stage of 
development, type (e.g., drug, device), use (e.g., therapeutic, diagnostic), comparison 
with similar technologies on the market; 
3. Impact predictions: health impact; ethical, social, cultural, and cost impact. 
At the end of the assessment, some considerations on how the technology could affect 
current policy and practice are presented, in line with horizon scanning approach. Particularly, a 
summary of the above mentioned Horizon Scanning focal points. 
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2.2.1 Patient- and setting-related information 
The area of interest investigated for designing the technology is related to patients with 
chronic conditions. Indeed, solutions for improving management of chronic conditions are under 
the attention of healthcare systems, due to the increasing prevalence caused by demographic 
change and better survival, and the relevant impact on healthcare expenditures. 
For example, according to International Diabetes Federation (IDF) data, the absolute 
number of diabetics in the EU will rise from approximately 33 million in 2010 to 38 million in 
2030. In 2010, approximately 9% of the adult (20-79 years) EU population was diabetic. 
Diabetes mellitus and its complications (including: diabetic retinopathy, kidney failure, heart 
disease, neuropathy and diabetic foot disease) have become a major public health problem in all 
countries. It causes significant physical and psychological morbidity, disability and premature 
mortality among those affected and imposes a heavy financial burden on health services. The 
prevalence of diabetes and complications can be reduced through early and appropriate 
intervention. Within Europe, important differences between potential risk factors (lifestyle, 
environmental factors, genetic predisposition, etc.) exist [109]. Morbidity rate and economic 
burden of diabetes in EU are 8.5% (estimation 10.3% in 2023). In particular, there are 3 
categories of costs associated with diabetes: 
 Directs costs: Diabetes is costly for the health care systems because of its chronic 
nature and particularly because of the gravity of its complications. Diabetes 
complications require hospitalization most of the time. 50% of people with diabetes 
suffer from at least one complication. Hospitalization represents the biggest 
proportion of the direct costs; 
 Indirect costs: Diabetes causes a loss of productivity because of disability, sick leave, 
early retirement and premature death. Indirect costs are often higher (up to 5 times) 
than direct costs; 
 Intangible costs: Diabetes influences the quality of life of patients (suffering, anxiety, 
and discrimination sometimes). It can also affect their social life and their leisure 
time. Their mobility can also be reduced because of the disease. 
The typical severe events of diabetes are hypoglycemia and glycemic decompensation due 
to hyperglycemia. In order to avoid severe events, complications it is of paramount importance 
that the patient plays an active role in the care plan. The latter must include a program of 
diabetes self-management education, a useful process for the patient in order to acquire the 
fundamental skills to correctly interpret the symptoms and blood glucose levels and to take 
corrective action autonomously. In order to reduce the costs of treatment, to improve the quality 
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of life and to reduce the need for insulin in insulin-dependent patients, it seems necessary to 
accompany the care plan a medical nutrition therapy that takes in account the needs of the 
patient and a regular physical activity. It is recommended to include in the follow-up of the patient a psychological evaluation, because of the patientǯs distress and helplessness caused by 
the restrictions due to the disease. Patient-collected physiological data, such as blood glucose 
levels, glycated hemoglobin, and blood pressure, body weight should be monitored. Moreover, 
predictive models are available (e.g., Archimedes) but not often used. An adequate Decision 
Support System (DSS) should be provided to patients to empower the patient in self-
management. 
Another common chronic disease is heart failure (HF). It is a pandemic syndrome: it affects 
2-3% of patients in the general population, with incidence increasing progressively with age and 
reaching 10-20% in aged population [110]. Male gender, advanced age, more severe symptoms, 
coronary artery disease, hypertension, impaired renal function, hyponatremia, and elevated 
plasma brain natriuretic peptide concentration are all factors associated with poorer prognosis. 
Despite HF prognosis has improved in the last decades, it remains very poor: near 50% of 
patients worldwide die within 5 years from diagnosis (remains worse than that of many 
common malignancies). The condition has a major impact on many aspects of an individualǯs 
quality of life, which is regarded as being worse in HF than in chronic lung disease, arthritis, or 
diabetes. The improving prognosis, coupled with a rapidly aging population, is driving a steep 
increase in the total number of people with HF: conservative estimates suggest that 6 million 
Europeans have this syndrome.  
Moreover HF is tremendously expensive representing about 2% of national health 
expenditures. It is the primary cause of 5% of hospital admissions in Europe (20% after 65 
years) and is present in 10% of hospitalized patients. Readmission rates are high: 30-40% of 
hospitalized patients are readmitted after one year (WHO reports 2011, ESC Heart failure 
guidelines 2012, AHA Heart Failure guidelines 2013).  HF presents high direct and indirect costs 
(morbidity, unpaid care costs, lost productivity, premature mortality), with more than 60% of 
total cost related to hospitalization.  
Although heart failure presents enormous healthcare burdens, outcomes are highly variable 
and predictive models may give important contribution to the patient assessment. Indeed, 
improving both in-hospital treatment and home care are the goals of HF management and their 
achievement can be measured assessing the impact in national health system of hospitalizations, 
emergency department accesses, non-scheduled cardiologic visits due to heart failure and 
patient stabilization, and Quality of Patient Life. To this end, score systems have been introduced 
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and some of those have been validated (e.g., Seattle Heart Failure Score, MAGGIC score), but 
predictive models are not often used in the clinical practices. 
Regarding home care management of HF patients, much of healthcare utilization is thought 
to be preventable if patients engage in consistent self-care.  
Many aspects of self-care monitoring have been evaluated and validated in heart failure 
management: 1) medication taking, 2) symptoms monitoring, 3) dietary adherence, 4-5) fluid 
and alcohol restriction, 6) weight loss, 7) exercise, 8) Smoking cessation, 7) preventive behaviors 
(such as influenza  vaccination). Depression, anxiety, comorbid states, age related issues, 
incomplete disease knowledge are known factors that can make self-care difficult for the patient. 
More generally, in their everyday lives, patients with chronic diseases deal with a range of 
conditions that require self-management and relevant decision-making. The attention to 
chronicity is acquiring worldwide relevance also because of the steadily increase in associated 
costs due to demographic changes and better survival rates of patients with chronic conditions 
[111]. The reduction of costs associated to the management of chronicity is one of the main 
challenges healthcare systems have to face. 
Upon hospital discharge, the multidimensional aspects of patientǯs care converge into a 
combination of clinical conditions  (co-morbidities, reduced functional capacity and self-
sufficiency, depressive and anxiety symptoms), psychological needs (awareness, acceptance, 
redefinition of self, self-efficacy, empowerment), and social challenges (loneliness, family/social supportȌ which may ultimately significantly affect patientǯs adherence and well-being [112]. 
Several approaches are currently being adopted to promote and sustain patientǯs 
adherence; among them, there is patient education (cognitive-behavioral individual and/or 
group interventions [113], nurse interventions, workshops, printed material, online 
communication); patient reminders (e-mails, tele-calling, text messages); pharmacy-based 
programs; collaboration with patient organizations, etc. Research has shown that the 
multifaceted aspects of adherence require multiple tactics to prove successful in time [114]. 
Between 2013-2016, Friuli Venezia Giulia Region has been leading a EU-funded, 24-region 
project on ICT-supported integrated care to provide domiciliary care to fragile, elderly European 
citizens. The experience has shared light on the needs and the maturity level of elderly citizens in the learning and use of technology and has highlighted patientsǯ willingness to be actively 
engaged with their healthcare/social care teams in the management of their own health. 
Preliminary results show the empowering aspect of technology for senior citizens [115]. 
The implementation of mobile technologies may support a healthcare redesign based on 
disease management programs and integrated care models [116] [117] [118] [119]. 
Furthermore, mHealth technologies may act as a complementary tool to provide support and 
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motivation to regular patientǯs self-monitoring of health parameters (e.g., blood pressure, heart 
rate, blood glucose) [120]. The resulting empowerment may help patients to achieve personal 
health objectives, modify lifestyle patterns and/or high-risk behaviors for an optimal 
management of their chronic condition [121]. 
Currently, over 35,000 mHealth apps for different health conditions are available for iOS 
and Android platforms [122]. Nevertheless, many challenges are still to be faced, such as open 
architecture [123] [124], medical devices directive applicability and data protection [125] [126], 
interoperability and integration in existing healthcare models [124], [127]. Most mHealth 
solutions rely on an architecture that only addresses one specific disease and are usually either 
all-online or all-offline [128]. Furthermore, these applications have been developed 
independently as stand-alone applications and are not easily integrated into existing healthcare 
models. Success of m(ealth solutions depends also on their ability to address and meet usersǯ 
needs. The diversity of needs and requirements comes from different age, sex, pathology, health 
status, environment and professional and social activities. The adaptability of the system in 
terms of customization and personalization is of paramount importance. Moreover, among 
others, health-related data are one of the most sensitive issues, and they are being protected by 
laws and regulations. However, it is well known that digital data, especially in a mobile 
environment, pose a huge security risk in terms of privacy violation [128]. The protection of 
health data is still a mHealth burning issue, which has to be handled properly. Data collected by 
sensors and coming from other sources do not impact only on storage and transfer capacity, but 
also require the ability of the system to analyze a large amount of information. Clinicians and 
patients are not interested in single data, rather in trend and overall scenarios. Therefore, the 
development of an intelligent system for data analysis and Decision Support Systems is essential 
for helping patients along their clinical pathways [129]. 
Many DSSs are available in current literature, but they are seldom based on validated 
predictive models and even though some scoring systems have been validated (e.g., Seattle Heart 
Failure Score [130], Archimedes [131]), predictive models are not often used in clinical practices. 
Moreover, beyond the above-mentioned considerations, a crucial aspect needs to be tackled 
anytime an IT solution has to be developed, i.e. the psychological and social implications of the 
new technology from the patientǯs point of view. )n order to answer these needs, a suitable 
approach must be found for meeting three major requirements: increasing self-management, 
self-awareness and social inclusion of patient/s within their communities. 
Actually, self-management may reduce the number of severe events (e.g., hypoglycemia and 
glycemic decompensation due to hyperglycemia in case of diabetic patients), thanks to the active 
role played by patients in their care plan. Furthermore, educational programs concerning, for 
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example, self-management education, acquisition of the fundamental skills to correctly interpret 
the symptoms and to autonomously take the relevant corrective actions are of paramount 
importance [132]. 
Secondly, self-awareness is being considered increasingly important. Self-monitoring has 
shown to enhance self-awareness and plays a substantial role in most behavioral programs aimed at promoting patientǯs adherence to therapy [133]. Research shows that people judge a 
risk not only by what they think about it but also by how they feel about it. If their feelings 
toward an activity are favorable, they tend to judge the risks as low and the benefits as high; if 
their feelings toward the activity are unfavorable, they tend to make the opposite judgment, i.e. 
high risk and low benefit [134]. )nterventions aimed at improving userǯs risk perception need to 
draw their rationale on the understanding of the psychological mechanisms and relevant 
theories underlying human behavior and motivation, in order to bring effective and long-term 
outcomes. 
Finally, social inclusion plays a key role in understanding, accepting and handling the 
complexities of change which are inherent to a life-limiting chronic illness [135]. 
In this process, positive communication is essential: in fact, whilst perceived negative 
change may lower self-esteem and hinder self-care, positive handling of change may increase 
self-awareness, self-worth and boost self-management skills. 
Summarizing, the main issues above mentioned highlighted at the state-of-the-art are 
related to open architecture, interoperability and integration, compliance with medical device 
directives and data protection, customization and personalization, DSSs based on validated 
predictive models as well as  psychological and social implications. The target of the evaluated 
technologies regards those for patients affected by the most frequent chronic conditions (e.g., 
diabetes, HF) with no severe mental and physical disabilities. 
A detailed description of the most important features an emerging technology for patients with chronic conditions should address, with particular attention to patientsǯ needs and in 
accordance with the most recently findings and emerging techniques, is presented in the 
following subsections. 
Mindfulness 
Mindfulness has been defined as a kind of non–judgmental, present-centered awareness in 
which each thought, feeling, or sensation arising within the perimeter of our attentional field is 
acknowledged and accepted [136]. Within this process, the person moves toward a state in 
which one is fully observant of internal and external stimuli in the present moment, and open to 
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accepting rather than trying to change or judge whatever arises to their conscience [137]. Baer 
[138] suggests that mindfulness may promote exposure to previously avoided internal experiences, thus promoting cognitive change or a shift in attitude about oneǯs thoughts, while at 
the same time increasing acceptance. According to Teasdale and colleagues [139], mindfulness 
practice may increase metacognitive awareness, a process through which negative thoughts and 
feelings are experienced as mental events rather than as the self. Moreover, a mindfulness-based 
approach has been incorporated within dialectical behavior therapy [140]; the combination of 
training and implementation of mindfulness meditation with cognitive therapy has been seen to 
significantly reduce relapse rates in recurrent major depression [141].  
Mindfulness goes beyond the simple practice of meditation; in fact, meditation practice is simply a ǲscaffoldingǳ used to develop the state, or skill of mindfulness [142]. Meditation is also 
often recommended as a practice that can be applied as a stress-reduction procedure to deal 
with a variety of health-related problems such as pain management, hypertension, and cardio-
vascular diseases [143]. There is an increasing number of studies of acceptance, mindfulness, 
and values-based action in relation to chronic pain. Also, whilst cognitive-behavior therapy 
(CBT) has proved its effectiveness in treating depression and anxiety disorders [144], a 2012 
Cochrane review [145] outlined that only 38-77% of patients suffering from chronic pain 
responded to CBT by experiencing clinically significant relief. Mindfulness-Based Cognitive 
Therapy (MBCT) may thus prove effective by its four-stage therapeutic approach which is 
designed to help people modify their thought process rather than the mere content of their 
thoughts [146]. Within a beehive person-centered approach [115], whereby each person is at the 
center of an integrated process of mutual care, mindful empowerment may thus turn out to be a 
pivotal issue in the development of innovative solutions for patients with chronic disease. 
Social inclusion 
Healthcare delivery is presently mainly focused on face-to-face interactions. However, 
mobile technology may act as a complementary tool to provide support and motivation to regular patientǯs self-monitoring of health parameters (e.g. blood pressure, heart rate, blood 
glucose, etc.). Social media may help decrease the burden of a chronic disease and become 
eHealth partners by providing Care Recipients with real-time access to care and social support. 
The resulting empowerment may help Care Recipients to achieve personal health objectives, 
modify lifestyle patterns and/or high-risk behaviours for an optimal management of their 
chronic condition. When Care Recipients are networked with each other through social media 
platforms, they shift from being passive recipients of healthcare to being active actors. Thanks to 
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the ubiquity of mobile devices, social media networks may provide unique social support, by 
combining motivation and education for patients suffering from a chronic illness. 
However, from an ethical perspective, this is an important aspect to consider. Indeed, 
technology may also cause dependence and isolation from the outside world. To this end, it is of 
paramount importance, trying to find ways for letting patients interact each other in a real 
context. From this perspective, mobile technology should be exploited as a mere tool for 
increasing social inclusions and independence, even from the technology itself. 
Gamification Gamification has a good impact on motivating usersǯ behaviors; it also plays a crucial 
educational role, since motivation is one of the basic conditions to learn. Moreover, it has also 
been proven successful for empowering patients to adopt healthy lifestyle [147]. Gamification 
mechanics are already represented in several mHealth applications and are an encouraging 
implementation for incentivizing improved patient self-management [148] [149]. It has also 
been reported that gamification improves engagement, compliance to therapy and learning 
[150] [151]. Furthermore, gamification alone or with social support may increase physical 
activity and empowerment and decrease healthcare utilization [152]. 
As far as the anxiety experienced by patients with chronic disease, the theorystates that the 
underlying causes of anxiety disorders may be found in a dysfunctional cognitive bias, whereby 
the individual develops an over tendency to pay attention to danger, ignoring any sign of safety 
and/or pleasure. This fearful state of mind determines what is called Ǯskewed attentionǯ. )n order 
to modify this dysfunctional attention bringing to anxiety and stress, non-threatening 
gamification-supported competition is developed to train the subject away from threat/danger 
cues [153]. In fact, games can be used to drive positive change in health-supporting behaviors by 
rewarding players for accomplishing desired tasks (positive reinforcement) and by taking 
advantage of natural competitiveness within a friendly, mutually supportive environment. In order to avoid ǲnagging effectǳ, constructive messages are provided to support individual and group motivation so as to boost userǯs self-esteem and reinforce positive behaviors. 
Education 
As previously introduced, education plays a crucial role in patients with chronic conditions. 
Indeed, review of the literature [154] demonstrates that education increase patient compliance 
(average improvement = Ͳ.͸͹σ over control, p < 0.05), and improve physiological progress ȋͲ.Ͷͻσ, p < 0.01Ȍ and health outcome ȋͲ.ʹͲσ, p < 0.05). 
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Decision Support System 
Currently, many practitioners use validated medical predictive models related to the 
selected chronic conditions and medical guidelines (e.g., Diabetes: Archimedes [131], EAGLE 
[155], GDM [156] and ADA guidelines [157]; HF: Seattle HF model [130], MAGGIC [158] and 
European Society of Cardiology guidelines & education). 
Decision Support System is increasingly used, since it may improve patientsǯ health status. 
Indeed, review of the literature [129] demonstrates that Decision Support System has been 
proven to significantly improve clinical practice in 68% of trials. Moreover, it may improve 
chronic disease management which requires recurrent visits to multiple health professionals, 
ongoing disease and treatment monitoring, and patient behavior modification [159]. 
2.2.2 Technology-related information 
The name of the assessed technology is GamyCare, an innovative mHealth solution, aimed at 
boosting the active and informed participation of patients in their care process, overcoming the 
current technical and psychological/clinical issues highlighted by the existing literature. It was 
designed by the Biomedical and Clinical Engineering Group of the University of Trieste in 2015. 
It can be considered as an emerging technology, since it is currently being developed. 
A detailed description of the technology is provided in the present section, in accordance with the aforementioned clinical, psychological and social needs ȋe.g., patientsǯ self-management, 
self-awareness, empowerment, social inclusion, positive communication). 
Mindfulness 
GamyCare answers the need for increasing self-awareness through the integration of 
mindfulness. 
GamyCare supports a mindfulness-based intervention through a tailor-made path so as to 
allow beginners to incorporate mindfulness practices in their everyday lives. As with any other 
intervention, mental health pre-screening and regular supervision need to be carried out by the  
clinician so as to rule out the presence of mental disorders which may put the patient at risk. The specific path ȋin terms of ǲentry levelǳȌ is evaluated by administering the Five-Facet Mindfulness 
Questionnaire [138] to the patient, designed to assess a core characteristic of dispositional 
mindfulness [160]. This approach takes into consideration specific patientǯs needs allowing system 
personalization. The overall path of the approach is listed below: 
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 Awareness of the five senses; 
 Visualization exercises (e.g., bodyscan); 
 Mini-guided meditation sessions; 
 Daily reminders to bypass the risk of alarm fatigue so as to promote adherence; 
 A motivational calendar to enhance self-care and prosocial behavior; 
 The user will become part of a mindful community which reinforces each otherǯs behaviors and enhance both individualǯs and social healthcare responsibility; 
 Successful adherence and behavior modification will be signaled to the user through 
easily readable health indicators which will provide cognitive and emotional 
reinforcement. 
Piazza Grande 
GamyCare enhances the importance of social inclusion of patients affected by chronic 
conditions in the real life through the implementation of Piazza Grande. Piazza Grande is a 
virtual meeting point where calendars of city health-promoting events can be shared, thus 
providing a means to meet in real life and share experiences (e.g., diaries and pictures) with 
those care recipients who are unable to join due to their serious health conditions. Particularly, 
Piazza Grande serves as a gateway to the people who matter to the patient/user and also 
connects individuals with the same conditions. Several interactions can be made between among 
subjects to improve engagement and reduce loneliness in some scenarios. Mindfulness may be 
promoted and enhanced within the virtual group of users, by sharing not only experiences, but 
also moments of practice and mutual support along the lines of social learning [161]. Not only 
patients can access to the Social Network Piazza Grande, but also all the people in their ǲreal-life networkǳ can be part of it, such as healthcare professionals, relatives, friends, caregivers. Piazza 
Grande may also benefit from the support provided by the Third Sector (e.g., college students 
enrolled in medical and/or nursing schools) who may, in turn, learn better and more effective 
ways to take care of their own health and well-being. This may actually promote healthier lifestyles among a wider community of Ǯhealthyǯ users. To this end, different access levels will be 
defined in order to guarantee the privacy of the patient. In a person-centered solution, patients 
can be connected to the people who care for their health and who can help them learn self-
management and accountability skills. 
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Figure 4 - Network Model of Care included in Piazza Grande 
Gamification 
GamyCare is based on gamification to promote patientsǯ self-management and enhance their 
empowerment.  
The gamified approach is carried out in both passive and active ways: in the first one, by 
using a gamified virtual representation of their health status avatar (VHA), the patient watches 
(and reacts) as that persona represents their own health, enhanced also with the support of the 
DSS. Furthermore, the automatic measurement of biosignal data is translated into changes on the 
VHA. The active way represents a more direct approach of the gaming concept, i.e. this pertains 
to activities that the patient/user consciously comprehends to be games: challenging another 
user to a jogging or cycling game, a trivia competition about a particular condition, compare 
recent healthy lifestyles and be rewarded, etc. 
Scope of the mindfulness-based gamification approach is to promote usersǯ perception and 
awareness of risks while simultaneously reinforcing risk prevention userǯs-led behaviors 
through a set of easy-to learn, simple-to-use and noninvasive techniques which may promote individualǯs awareness, empowerment, and role modeling. 
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Education 
GamyCare educates and trains patients both to learn about their pathology and to better 
understand how mindfulness and the other integrated tools may help them in improving their 
quality of life. The concept behind GamyCare approach is that the more patients know about 
their condition, the more they can better manage their health, also in terms of self-management 
and promotion of adherence to therapeutic prescriptions and healthier behaviors (decreasing 
the risk behaviors and risk factors). The educational contents are shared with patients through 
different tools and interaction modalities ȋvideo, audio, textȌ in the userǯs mother tongue, and the educational content is tailored to the patientǯs background in accordance with the preliminary 
assessment results. Moreover, through a self-regulated learning process, patients can select the 
goals (challenges) they want to reach, following a gamified approach. 
The patient/user can constantly access a detailed and comprehensive database of 
information about their conditions, as well as relevant updates concerning, for example, new 
important findings. Moreover, training and education are provided with a positive approach in 
accordance to the mindfulness and gamification concepts. 
Decision Support System 
To empower patients to participate in the management of their health through applications 
for their disease, lifestyles and prevention monitoring, it is necessary to increase their 
consciousness about their health conditions and risk awareness. To this end GamyCare provides 
users with a personal monitoring system empowered by a Decision Support System which 
provides feedback about their health status, predicts health evolution and provides patients with 
warning alerts. The patient-specific data (e.g., biomedical, clinical, therapeutic, environmental, 
social data) are processed in real-time by prognostic and diagnostic algorithms based on 
artificial intelligence and computational models. These models and algorithms include validated 
medical predictive models. The prediction is accompanied by personalized suggestions which 
encourage patients to healthier behaviors and lifestyles. Moreover, the implemented DSSs 
generate medication reminders and warn patients on the consequences of non-adherence to the 
prescribed protocol. 
GamyCare aims to boost the use of existing validated predictive models by implementing 
them into a comprehensive mHealth solution supported by gamified representation and 
prediction of health status, and also by providing relevant recommendations based on clinical guidelines. Thus, modelsǯ outputs may become more useable and understandable to the patient 
thus increasing their everyday use and diffusion. The lack of large validation clinical trials and 
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the shortage of personalized validated predictive models are problems that still need to be 
tackled. 
Preliminary Patient Assessment 
In order to assess in a real life context the need for a support to self-management and to 
lifestyle improvement, and in order to evaluate the acceptance level of our technological solution 
designed to relieve chronic disease burden, narrative medicine semi-structured interviews and 
Psycho-Social-Assessments (25 questions on physical, psychological and social well-being on a  
5-item Likert scale rated on intensity/frequency of experience) were administered to a random 
sample of 22 patients, stratified by age and sex, attending the Chronic Care outpatient clinic at 
the Cardiovascular Center of Health Authority n°1 Triestina (Trieste, Italy). The sample of the 
interviewed patients was composed by 85% males and 15% females (mean age 76±9) with 8.5 
(±3) years of education. 44% suffered from atrial fibrillation and 92% were in polytherapy with 
at least 4 medications. Furthermore, comorbidities included type II diabetes in 85% of patients, 
moderate to severe renal failure in 16%, hypothyroidism in 20%, and COPD (Chronic Obstructive 
Pulmonary Disease) in 8% of them. Patients had been previously screened and tested negative 
for cognitive and memory impairments. The semi-structured interviews were built on a grid 
which focused on the experience of illness, relationships with healthcare providers, supportive 
role of social network, beliefs concerning illness and adherence, self-awareness in everyday life, 
self-efficacy, self-report of mindful day-to-day experiences, empowerment/disempowerment, 
attitudes and behaviors related to adherence to therapeutic regimens and lifestyle changes, as 
well as technology-related attitudes and beliefs. Each narrative interview was audio-recorded 
and transcribed verbatim. Guidelines for grid construction in the domains of self-awareness and 
self-empowerment included questions from the MAAS (Mindful Attention Awareness Scale) 
which assesses dispositional mindfulness, (i.e., receptive awareness of and attention to what is 
taking place in the present) and from the PAM (Patient Activation Measure) which assesses 
patient knowledge, skills, and confidence for self-management [50]. 
The questionnaire results are summarized in Figure 5. As it is shown, 80% of patients with a 
chronic cardiovascular (CV) disease have difficulties staying focused in their everyday 
experience; 78% reported trouble in adequately responding to shifts in the environment and 
55% stated that they have trouble noticing distressing thoughts without having an 
emotional/physiological reaction. The majority of interviewed patients (73%) felt 
disempowered as far as decision-making on health issues and treatment is concerned, and 76% 
of patients mistrust their self-care abilities. Interestingly, despite the advanced age of the sample, 
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60% of patients expressed either knowledge of, or interest in new communication technologies 
(e.g., mobiles, web-learning, social platforms). 
 
 
Figure 5 - Results of the preliminary assessment (from [47]) 
Though limited in scope, this qualitative screening sheds some light on the evolving needs 
for self-awareness and empowerment of patients suffering from chronic care conditions and has 
reinforced our approach to design the most effective solution for patients with chronic 
conditions. 
2.2.2.1 Overall architecture 
In order to establish an advanced system to monitor and support patients with chronic 
disease, GamyCare has been designed to meet the following technical requirements, considered 
important aspects as stated in our introduction: 
 Open architecture in order to provide a scalable system, customizable to patients 
affected by different chronic diseases; 
 Compliance with transfer and data protocols to ensure interoperability with existing 
wireless devices; 
 Application of semantic web approaches and standards to ensure correct sharing of 
information with hospital information system, and classification of patient behaviors; 
 Compliance to the existing standards and regulations; 
 Guarantee security and privacy protection of health and personal data. 
55%
73%
76%
78%
80%
60%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90%
distressing thoughts
empowerment and decision-making
trusting in self-care abilities
responding to shifts in the environment
staying focused
interest in new communication technologies
Preliminary assessment results
Trouble related to: 
 
 
CHAPTER 2 ASSESSMENT AND DESIGN OF INNOVATIVE TECHNOLOGY: GAMYCARE 
 
 
 
52 
 
 Each module of GamyCare architecture is shaped on specific patientǯs disease and condition 
states, so as to provide each user with a personalized solution. Even though the modularity can 
introduce limitations (e.g., increasing size and mass due to some redundancy and using standard 
components designed for more general applications), it allows customization, scalability and 
applicability to different kinds of chronicity. 
Furthermore, the security, safety and interoperability of our technology are guaranteed 
through the compliance with existing standards. Notably, it is compliant with the ISO/IEC 
27001:2005 which provide best practice recommendations on information security 
management, risks and controls within the context of an overall information security 
management system (ISMS). Moreover, data acquisition is compliant with data transfer 
protocols (e.g., BT4/LE, ANT+, ISO/IEEE 11073) in order to ensure integration with existing wearable devices. Patientǯs data are stored in accordance with privacy and safety legal 
requirements through the application of standard communication protocols (e.g., HL7, ICD-10 
and openEHR) to ensure correct information sharing with hospital information systems and, 
eventually, Electronic Health Record (EHR). 
In order to comply with the identified needs and requirements, the overall architecture 
(shown in Figure 6) can be divided into two parts: patient side (mobile) and server side.  
Patient side and server side are both based on 3-tier architecture involving three physically 
separated layers: Presentation (or Client) Tier is the user interface. On the patient side, it is 
based on the gamification technique both for presenting and collecting data; on the server side, 
the view level of collected and processed data depends on the role of the logged user (i.e., 
healthcare professional, caregiver); Business Logic (or Application) Tier coordinates the 
application, processes commands, make logical decisions and evaluations, and performs 
calculations. It also moves and processes data between the two surrounding layers (Presentation 
and Data Tiers); Data (database) Tier stores and retrieves information, which is passed back to 
the Logic Tier for processing. Particularly, on the server side, data are permanently and safely stored, in compliance with the requirements for guaranteeing userǯs privacy; conversely, on the 
patient side, data are transitory since the database is a buffer filled with data coming from the 
server and the newest acquired data which are subsequently sent to the central database. 
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Figure 6 – Overall Architecture (from [47]) 
On the patient side, a mobile application provides features and services to the patient. Through the gamification GU) module, better patientǯs self-care may be promoted and enhanced. 
Data which are automatically collected by biomedical and environmental sensors through the 
sensor interface, as well as self-reported data, are validated to provide real-time risk 
warnings/alerts whenever recorded values are out of range of safety, even when internet 
connection is not available. Particularly, Internet connection allows for buffered collected data to 
feed the DSS on the server side and to obtain remote health status monitoring and prediction of 
health evolution, accompanied by behavioral, lifestyle suggestions and social support provided 
both by caregivers and clinicians. Therapeutic reminders are also ensured in case of Internet 
service interruption. As sensitive data, they are being stored in the central database. However, a 
message reminder is locally scheduled on the Patientǯs device without therapy explicit 
references. Connection is needed to view the full text reminder with therapeutic details.  A 
reminder engine collects all the important reminders (e.g., scheduled appointments, drugs 
reminders, diet, and lifestyle suggestions) and it is synchronized with the central database on the 
server side when Internet connection is restored. Synchronization, remote support and feedback 
on therapeutic compliance are only some of the features that are provided to the patient through 
ClinicianCaregiver
SLL Encription
Environment Biomedical Self reported
Patient’s Record
Sensor 
Interface
Gamification 
GUI
WS Client 
Interface
Alerting 
Engine
Reminder 
Engine
Buffered
Data
tmp
Data 
Validation
Web Service 
API
Web 
Application
Access Control
Centr
al DB
DSS
Data Access 
Layer
 
 
CHAPTER 2 ASSESSMENT AND DESIGN OF INNOVATIVE TECHNOLOGY: GAMYCARE 
 
 
 
54 
 
the web services API. This API represents the interface module between the web service client 
interface on the patient side and the server side. The API also manages SSL encrypted traffic 
made up of all medical history and other sensitive data, interactive educational tools and 
contents, and social network interactions.  No personal and/or sensitive data are stored on the patientǯs device. (istorical data are 
stored on the central database.  Conversely, the newly acquired data are used for urgent advices 
and not for consulting scope and, to this end, they are available in off-line mode until the 
connection is restored. Those data are temporarily stored in the buffer module after their 
validation. This also allows better management of a large amount of information, since data are 
only stored in the central database receiving and sending out necessary data on demand. On the server side, as already briefly stated, patientǯs data are stored and monitored. Caregivers and healthcare professionals get patientǯs health information through the web 
application module where aggregated data and graphs, processed by the DSS module, are presented and defined in accordance with different levels of usersǯ access. The DSS is the most 
important module of the business logic tier, and it is based on a relational database management 
system where data are stored in a disease-centric manner, as it is shown in Figure 6. The 
connection of this database is handled by the Data Access Layer that also grants access to its 
data. 
The Entity-Relationship model of the database is represented in Figure 7. Particularly, the 
entity Disease represents the core of the system and it is managed by a specific DSS module. 
Disease is linked to one or more Professional (e.g., health specialist), and User is linked to one or 
more Disease. Each user can be followed by zero or more caregivers (e.g., relatives, friends) and 
also follows the mindfulness program starting from the appropriate level in accordance to their 
background. Mindfulness programs and DSS modules provide users with suggestions, exercises, 
and educational contents. In the database architecture, Patient’s Record (e.g., self-reported data) 
are linked to a specific Disease and can be required by DSS Module and Mindfulness Program 
through Suggestion & Exercise, should patients be required by the system to perform 
measurements or other tasks, or provide feedback. Possible Signal DataSet resulting from the processing algorithms are stored as ǲchildrenǳ of correspondent Patient’s Record (e.g., 
biomedical and environmental signal). 
This overall database architecture allows DSS to define the proper contents to show according to the tracking progression of patientǯs status. Moreover, Disease centrality permits to 
easily connect Users, Caregivers, and Professionals in the same area of interests (through the ǲlocationǳ attribute, based on GPS). 
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Figure 7 - Database architecture: Entity Relationship (ER) model of the database (from [47]) 
2.2.2.2 Comparison with similar technologies 
Table 9 presents a comparison of GamyCare with similar technologies already in the market. 
Some indicators, considered important at the state-of-the-art and identified by the JRC European 
Commission as major gaps of technologies currently on the market were selected, providing an 
overview of the assessment. The indicators correspond to the criteria considered in HTA and 
they are 13 (more than 11, as it is the minimum number within a rapid review, as discussed in 
the introduction of Paragraph 2.2) 
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Table 9 – Features (gaps underlined by the JRC European Commission) addressed by GamyCare compared with other 
solutions available in the market 
According to the main purpose of GamyCare to overcome the current limitations at the 
state-of-the-art, as shown in Table 9, GamyCare was designed to be compliant with all the 
features underlined as major gaps the JRC European Commission. Indeed, it provides integration 
with clinical evidence and guidelines adopting know-how of medical guidelines and validated 
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medical predictive models. The latter ones allow also to predict the health status according to 
the data acquired by the system. This is possible thanks to the personalized processing of data 
collected through multiple sensors and directly inserted by the user, according to their specific 
disease. This results in a continuous monitoring of health status of patient. GamyCare was 
designed for overtaking limitations related to channel constrains, providing multichannel 
delivery and interaction (e.g., audio, and visual), allowing patients to choose channels according 
to their preferences. Moreover, before starting to use the technology, it provides simple guide 
with instruction on how-to-use the device, providing tips and suggestions. Even though it is 
currently only designed, GamyCare will be developed with a particular attention for being 
compliant with external medical devices and electronic patient records, assuring its 
interoperability. Another important aspect GamyCare will take care of, is social inclusion of 
patients both through social networks and in real world, underlying the importance of 
considering the technology as a mere tool for improving real life. Lastly, the integration of 
mindfulness and gamification will provide a support for increasing awareness and enhancing 
self-management respectively. 
2.2.3 Impact predictions 
In accordance with the main features presented in the previous sections, GamyCare may 
provide relevant impacts in terms of improving patientsǯ quality of life, social life and awareness; 
enhancing adherence to therapeutic protocols; improving self-management of their chronic 
diseases; reducing economic expenditure. 
Impact predictions have been studied qualitatively and, together with an example of cost 
reduction, are described as follow: 
 Improving the management of a disease by reducing the number of severe episodes 
and complications: better disease management will be promoted through the support 
of GamyCare technology to enhance clinical and psychological self-monitoring and 
self-care skills while reinforcing health-promoting individual and social behaviors; 
 Increasing the importance of the prevention sector in healthcare using predictive 
modeling: better disease prevention will be promoted through the support of DSS, 
based on predictive models, and interactive education, to enhance clinical and 
psychological self-monitoring and self-care skills while reinforcing health-promoting 
individual and social behaviors; 
 Improving the participation of the patient in the care process: innovative 
gamification-supported mindfulness-based interventions, in synergy with PDSS, will 
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promote patientǯs motivation and active role in self-management to improve health 
behaviors (exercise, cognitive symptom management, communication with 
physicians), self-efficacy and health status, and increase their participation in the 
care process. The program will incorporate modeling and social strategies so as to 
enhance a sense of personal efficacy and empowerment; 
 Boosting the development of personal devices used for self-management of health: 
GamyCare will hardness the potential of latest technologies and new social 
communication forms with self-management person and people-centered 
interventions. In addition, the personalized PDSS will enhance a patient-oriented 
approach, boosting personal devices used for self-management of health; 
 Improving individual self-control of health and of disease prevention: GamyCare 
innovatively addresses self-management issues by combining technology-based 
support with a gamification and mindfulness-based cognitive-behavioral approach to 
increase risk perception while at the same time promoting awareness and proactive 
individual and social health-enhancing behaviors; 
 )mproving patientsǯ interaction with others in the real world: the implementation of ǲPiazza Grandeǳ will allow patients to feel more comfortable with their chronic 
disease through the support of persons sharing the same challenges; 
 Exploiting device features without creating technology-dependency: the main aim of 
GamyCare is to avoid user technology-dependency. This is the reason why particular 
attention is dedicated to Piazza Grande and automatic suggestions provided by the 
app aim to enhance patientsǯ autonomy in the real world; 
 Reduction of economic impact: a recent systematic review [162] states that 
integrated care models for patients with chronic diseases have a positive economic 
impact. For example, an America study [163] reported that total medical costs 
decreased by 26.8% from the baseline period, after the introduction of a diabetes 
disease management program that considers only a limited number of parameters to 
monitor. GamyCare does not only provide patients with a disease management 
program, but it also integrates methods for increasing awareness and well-being, 
thus leading to hypothetical results even more effective and cost-saving. However, 
applying a conservative approach of a cost reduction equal to 20%, and considering 
that the annual expenditure per case for diagnosed diabetes (type 2, less costly than 
type 1) is $ 9,677 [164], GamyCare may allow to save $ 1,935 per patient per year. 
Moreover, considering that diabetes prevalence is approximately 27.5 million people 
in the United States [165], the total cost-saving in the United States can be estimated 
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as more than $ 4 billion per month. The cost of GamyCare can be estimated as $ 10 
per patient per year, that is equal to $ 275 million per year. This esteem is certainly 
just an approximation that must be deepened, but it is sufficient to provide brief 
information on the economic assessment. 
2.2.4 Assessment summary 
The present section summarizes the most important information required by Horizon 
Scanning approach, as introduced in paragraph 2.2. 
Particularly, Table 10, Table 11, and Table 12 present patient- and setting-related 
information, technology-information, and impact prediction respectively, detailed described in 
each specific section of the present paragraph. 
 
Patient- and setting-related information 
Indication Incidence of patients with chronic conditions is increasing and technologies for improving 
both therapy programs adherence and self-management resulted to be effective. 
Programs for improving awareness through mindfulness and education, well-being through 
social inclusion, adherence through gamification and decision support systems, resulted to 
be successful 
Specialty Patients with chronic conditions, especially diabetics and hearth failure 
Patient numbers Diabetics: 9% of the total population. 
Hearth failure: 2-3% of general population (10-20% in aged population) 
Settings for 
technology use 
Patients in their everyday life 
Alternative or 
complementary 
technologies 
Most of the current solutions mainly focus on in person interaction with physicians and 
healthcare professionals, such as patient education (cognitive-behavioral individual and/or 
group interventions, nurse interventions, workshops, printed material, online 
communication); collaboration with patient organizations. Tools for improving patientsǯ adherence to therapeutic programs are usually based on 
patient reminders (e-mails, tele-calling, text messages)+. 
Tools for supporting practitioners for a better management of chronic diseases are based on 
validated medical predictive models and medical guidelines 
Table 10 – Summary of patient- and setting-information required by Horizon Scanning approach, as presented in 
paragraph 2.2, extensively described within the present chapter 
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Technology-related information 
Name GamyCare 
Description GamyCare aims to provide mobile, web-based tools and devices to keep patients with chronic 
diseases away from severe episodes and complications of illness, to improve their quality of life 
and to reduce their economic impact by promoting risk prevention, self-management of the 
chronic condition, and decision-making. 
GamyCare is hence designed to boost the active and informed participation of the patients in 
their care process, allowing them to manage their own health and increasing their awareness 
Company or 
developer 
University of Trieste, Biomedical and Clinical Engineering Group 
Stage of 
development 
Emerging technology 
Type Mobile app, web-based tools 
Use Therapeutic 
Comparison with 
similar 
technologies 
GamyCare was designed to overcome the current limitations at the state-of-the-art, and it has a 
competitive advantage compared to the similar technologies available in the market 
Table 11 – Summary of technology-information required by Horizon Scanning approach, as presented in paragraph 2.2, 
extensively described within the present chapter 
Impact predictions 
Health impact Improving the management of a disease by reducing the number of severe episodes and 
complications 
Health impact Increasing the importance of the prevention sector in healthcare using predictive modeling 
Cultural impact Improving the participation of the patient in the care process 
Cultural impact Boosting the development of personal devices used for self-management of health 
Cultural impact Improving individual self-control of health and of disease prevention 
Social impact )mproving patientsǯ interaction with others in the real world 
Ethical impact Exploiting device features without creating technology-dependency 
Economic 
impact 
Sensitive reduction of economic impact 
Table 12 –Summary of impact predictions required by Horizon Scanning approach, as presented in paragraph 2.2, 
extensively described within the present chapter 
2.2.5 Discussion and conclusions 
The approach of Horizon Scanning for designing an innovative technology, allowed to focus 
on the most important aspects to be considered for creating a competitive solution. Even though, 
as already stated, Horizon Scanning should be performed by external professionals in order to 
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avoid conflict of interests, the research resulted to be of help during the identification of the 
main features to be implemented. 
Particularly, the open architecture and approach offered by GamyCare were thought to 
overcome the main limitations of the present solutions available on the market, in terms of 
technical requirements (e.g., standards for interoperability and privacy) and humanistic and 
psycho-social needs (e.g., Piazza Grande). Regarding the latter, the integration of the DSS aims at 
improving the compliance of patients with their clinically devised pathway. With a view to 
strengthening the link between users and their health, the gamification approach has been 
introduced as an additional technique. Moreover, the enhancement of a positive psychological 
status, self-awareness and, consequently, quality of life is obtained through a mindfulness-based, 
self-empowering approach. Furthermore, the results of our preliminary assessment show the 
evolving needs for self-awareness and empowerment of patients suffering from chronic care conditions. The interviewsǯ and questionnairesǯ results show patientsǯ need to increase self-
empowerment and self-awareness and, at the same time, their interest in new communication 
technologies. Nevertheless, this preliminary assessment presents several limitations (e.g. small 
sample, elderly patient population, high specificity and severity/complexity of disease). Even 
though innovative cognitive-behavioral programs may promote awareness of self and support 
educational and clinical interventions, careful identification of the most adequate patient 
population (e.g. according to age groups, complexity and/or severity of disease as well as 
computer literacy) is advisable so as to maximize intervention outcome. 
Considering also the economic impact of the proposed solution, the described design should 
be developed in a short time, maintaining the competitive advantage. 
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2.3 Final remarks 
Conducting assessment of medical devices resulted to be different among the two 
considered technologies. Indeed, for the first assessment (technology already in the market), 
data of clinical outcomes (e.g., effectiveness) were available in the literature and comparison 
with other technologies was possible to undertake. The analysis was conducted in accordance 
with the most recent HTA approaches that focus primarily on providing evidences in a short 
time, instead of providing more robust statistical results with longer studies. This can be 
considered as a limitation of the study, even though it is worth reminding that the primary goal 
of the overall study was to provide a useful tool as a compromise between scientific approach 
and practical usage. Further analysis can be conducted using Multi Criteria Decision Analysis 
approach, identifying the most important criteria to be considered for assessing the best 
technique to be used in thyroidectomy, and involving a multi-disciplinary group of stakeholders. 
The second assessment (GamyCare) was more difficult to be compared with other 
technologies, since the proposed solution is not yet in the market. This resulted in an assessment 
that is closer to a market analysis, instead of an HTA. However, the Horizon Scanning approach 
described at the beginning of the chapter was followed. This allowed to identify the most 
important features to be considered for an innovative solution, aimed at overcoming the current 
limitations at the state-of-the-art, focusing primarily on patientsǯ needs, but also considering 
technical limitations. The main information (patient- and setting-related; technology-related; 
and impact predictions) required by Horizon Scanning were addressed, presented in detail 
within the chapter, and summarized in the last subsection. 
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Chapter 3 
Hospital services assessment and 
improvement 
Hospital services are under the attention of researchers and healthcare professionals, 
especially for improving quality and processes. One of the most frequently used approaches 
within this context is lean management. However, systematic assessments of hospital services 
are not in use, probably due to the lack of specific data in the literature that does not allow 
systemic review of the state-of-the-art. Since hospital services represent an important area to 
manage from clinical engineering perspective, this part of the study was introduced within the 
overall study and it aimed to analyze two different services: the first one is the Clinical 
Engineering Service, since it is the core hospital service of clinical engineering, and the second 
one is the Central Sterilization Service, since it is closely related to operating theatre procedures, 
that represent the core activity of hospitals. 
While Clinical Engineering Service was assessed through Multi-Criteria Decision Analysis 
[166], the Sterilization Service was firstly studied in terms of process improvement [167], 
applying lean techniques, and it was then assessed following HTA approach, integrated with 
Multi-Criteria Decision Analysis. The analyses were conducted in three different Italian hospitals. 
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3.1 Assessment of Clinical Engineering Services 
The aim of this study was to assess a Clinical Engineering Service, considering particular 
needs and constraints of the specific hospital. Particularly, the study aimed to fulfill the need of 
re-engineering the Clinical Engineering Service in an Italian ASL (Local Health Authority) located 
in Sardinia, in accordance with the Italian regulations for healthcare. 
Even if methods for processes redesigning in healthcare organizations are available in the 
literature, there are no recent evidences of their application in Clinical Engineering Services.  
Among the multi-criteria techniques, in this work PAPRIKA was used, since, as already 
discussed in the first chapter, it is an easy-to-use and intuitive method for multi-criteria decision 
making, based on decision-makersǯ preferences. We identified the decision makersǯ criteria to be fulfilled and four different preference levels 
for each criterion, as inputs of the method. Moreover four different scenarios were identified 
and, for each scenario and criterion, the decision makers selected the most suitable level. 
3.1.1 Introduction 
Accreditation process and compliance to mandatory standards are required worldwide by 
almost every hospital, in order to assess their level of performance and to implement ways to 
continuously improve. Even though the general purpose should be to adopt a unique set of 
requirements (such as the standards offered by Joint Commission International regarding 
Patient Safety, ISO series, or in the European Union the harmonization of law), the peculiarities 
of any single hospital and the requirements requested by a particular area must be considered. 
This results in the need of identifying the best personalized scenario shaped on the specific 
healthcare organization. 
In this study, we analyzed an Italian ASL placed in Sardinia in order to answer the need to 
redesign its Clinical Engineering Service (CES) in compliance with national and regional 
requirements for hospital accreditation. 
Particularly, the minimum requirements defined in national (DPR 14.01.1997 no. 37) and 
regional (Sardinia, DGR 47/42 30.12.2010) regulations for hospital accreditation involve: 
1. availability of procedures for managing biomedical technologies purchase, also based on 
their obsolescence in compliance with the technical regulation; 
2. availability of a plan for preventive and corrective maintenances of biomedical 
technologies. 
All the specific technological requirements are defined in checklists and questionnaires. 
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Furthermore, one more aspect to be considered concerns the actions to be undertaken for 
preventing adverse events due to malfunctions of medical devices, defined by the 9th 
Recommendation of the Healthcare Ministry in the Italian context. 
In order to address the need of solving a decisional process aimed at the identification of the 
best solution among the alternatives, different evaluation techniques are available in the 
literature, as presented in the first chapter and detailed in following paragraph. 
In the present paper the main research questions were as follow: 
 Which is the best solution to be implemented in the ASL for redesigning the 
biomedical technologies management, in compliance with law requirements? 
 What types of scenarios can we imagine? 
 What is the best method to be chosen for finding the most suitable solution? 
3.1.2 Material and methods 
Description of the context 
The Sardinian ASL investigated is composed by three hospitals for a total of 410 beds and 
3,960 biomedical equipment.  
The human resources of the Clinical Engineering Service are composed by: 
 1 Clinical Engineer; 
 1 Technician;  
 1 Administrative Assistant;  
 1 Assistant for warehouse activities and porterage. The CES of the ASL is configured as a ǲmixed serviceǳ: the internal clinical engineer is in 
charge of controlling the activities, and the assistance is provided by both an internal and two 
external technicians. Furthermore, some technologies are maintained by external companies. 
Multi-criteria approach 
Differently from the mono-criteria approach, the multi-criteria techniques use more than 
one evaluation criterion to choose the best solution. Indeed, it does not only maximize the result 
in terms of costs, but it aims to find the best overall solution, considering all the input variables, 
defined by the decision makers. 
The mono-criteria approach is usually based on the economic and financial elements and it 
is more easy-to-use than the multi-criteria ones. Nevertheless, the exploitation of the single 
 
 
CHAPTER 3 ASSESSMENT OF CLINICAL ENGINEERING SERVICES 
 
 
 
66 
 
economic and financial parameters does not always depict the actual perspective of the decision 
makers, and it does not allow considering qualitative factors. 
On the other hand, the multi-criteria techniques address the actual need of decisional 
problems, often based on multi-objectives, multi-decision-makers, and multi-dimensions, 
through a matrix of both qualitative and quantitative data. 
In this study, we adopted PAPRIKA, because, as detailed in the first chapter, differently from the other methods that measure decision makersǯ preferences through relative importance of 
each criterion, PAPRIKA quantifies the preferences through pairwise comparisons: this kind of 
comparisons are more natural and understandable, so that they can be considered more accurate and closer to the decision makersǯ preferences.  
On the other hand, the limit of this method is represented by the exponential growth of the 
number of comparisons. In order to overcome this problem, we used the 1000 minds, an online 
decision-making software developed by F. Ombler and P. Hansen [168], able to reduce the 
number of comparisons of PAPRIKA model. 
PAPRIKA has been already used in the healthcare context, such as for healthcare 
technologies purchase prioritizing [169] [170], and for surgical patientsǯ access prioritizing 
[171] [172]. 
Evaluation criteria and weights 
Before creating the model, the identification and selection of criteria, decision model, levels 
of preferences together with the alternatives and attributes must be undertaken. 
Initially, we identified four alternative scenarios that can be summarized as follow: 
1. Alternative A1: Current situation at the ASL (described in ǲDescription of the contextǳ 
section); 
2. Alternative A2: Outsourced management of Preventive Maintenance (PM), Testing (T) 
and Electrical Safety Verification (ESV) of all the biomedical technologies, except for the 
high technologies; 
3. Alternative A3: Compliance to an Italian Ministerial program (CONSIP, SIGAE 4) that 
provides some base activities (i.e., maintenances, replacement parts supplying, Electrical 
Safety Verification, computerized management of the provided services, call-center, 
biomedical technologies disposal planning, internal technicians training) for the 
management of all the biomedical technologies, except for the high technologies; 
4. Alternative A4: FULL RISK contract with a unique external company for all the 
biomedical technologies, except for the high technologies. 
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Subsequently, the decision makers identified, through a brainstorming session, six criteria 
of interest shown in Table 13. 
 
Criteria Description 
C1 Dimensioning of human resources at CES 
C2 Effects on the organization: work processes 
C3 Supervisory capacity of the administration 
C4 Quality of provided services 
C5 Emergency and urgent problems resolution 
C6 Annual costs the for biomedical technologies management 
Table 13 – Criteria of interest 
For each criterion, four levels of preference were defined, in terms of qualitative or 
quantitative parameters, depending on the specific criterion (Table 14). The levels of preference 
vary from L1 (option considered the best one) to L4 (option considered the worse one). 
The weights of each criterion are automatically calculated by 1000 minds, based on the 
answers provided during the pairwise comparisons. 
 
Criteria Level Description 
C1 L1 2 engineers, > 3 biomedical technicians 
L2 1 engineer, 3 biomedical technicians 
L3 1 engineer, 2 biomedical technicians 
L4 1 engineer, 1 biomedical technician 
C2 L1 A unique company in charge of all the activities management 
L2 A unique company in charge of MP and VSE 
L3 Different companies in charge of all the activities management 
L4 CES in charge of all the activities management 
C3, C4 L1 Excellent 
L2 Good 
L3 Sufficient 
L4 Insufficient 
C5 L1 Always guaranteed 
L2 Always guaranteed during working hours 
L3 Occasionally guaranteed during working hours 
L4 Never guaranteed 
C6 L1 ≤ ʹ million € 
L2 > ʹ million €, ≤ ʹ.ʹͷ million € 
L3 > 2.ʹͷ million €, ≤ ʹ.ͷ million € 
L4 > 2.ͷ million € 
Table 14 – Levels of preferences for each Criterion 
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3.1.3 Results 
Creation of the model 
After the definition of the four alternatives (A1-A4), the six criteria (C1-C6) and the four 
levels of preference for each criterion (L1-L4), the four decision makers (the General Manager, 
the administrative Director, the healthcare Director and the CES Director) assigned a level of 
preference to each criterion of each alternative and they all agreed with the preferences shown 
in Table 15. 
 
 C1 C2 C3 C4 C5 C6 
A1 L4 L3 L2 L2 L3 L1 
A2 L3 L2 L2 L2 L3 L2 
A3 L1 L1 L4 L3 L1 L1 
A4 L1 L1 L4 L3 L1 L3 
Table 15 – Decision makers’ levels of preferences 
The best alternative scenario was then selected through the 1000minds software, as it is 
explained in the following paragraph. 
Choosing the best solution 
The 1000minds software provides the user with pairwise comparisons, so that they can 
either choose the preferred alternative or none. 
Even if six criteria (C1-C6) and four preference levels, also called categories, (L1-L4) result 
in 46 = 4,096 possible alternatives (as described in the first chapter), the number of questions the decision makersǯ had to answer for letting 1000minds software able to select the best solution, 
was equal to 372 (69% of 540 potential questions, identified by 1000minds). 
The weights of each criterion are assigned by the software, independently from the 
preferences expressed by the decision makers at the beginning (in Table 15), and in accordance to the userǯs preferences selected through the pairwise questions. The weights resulting from the 
comparisons are presented in the radar chart of Figure 8. 
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Figure 8 – Radar chart of criterion weights 
The single score assigned to each of the six criteria is shown in Table 16. 
 
Criteria Level Single Criterion Score (0-100)  Criteria Level Single Criterion Score (0-100) 
C1 L1 0  C4 L1 0 
 L2 33.3   L2 35.0 
 L3 66.7   L3 67.5 
 L4 100   L4 100 
C2 L1 0  C5 L1 0 
 L2 50.4   L2 33.3 
 L3 83.3   L3 66.7 
 L4 100   L4 100 
C3 L1 0  C6 L1 0 
 L2 33.3   L2 33.3 
 L3 66.7   L3 66.7 
 L4 100   L4 100 
Table 16 – Single Criterion Score 
Moreover, the ǲMarginal Rate of Substitutionǳ ȋi.e., the rate at which the decision maker is 
ready to exchange an alternative for another one while maintaining the same level of utility) of 
the column criterion for the row criterion, has been calculated, and it is shown in Table 17. 
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 C3 C2 C4 C1 C5 C6 
C3 1 3.0 6.0 19.0 61.8 247.0 
C2 0.3 1 2.0 6.3 20.5 82.0 
C4 0.2 0.5 1 3.2 10.3 41.0 
C1 0.1 0.2 0.3 1 3.3 13.0 
C5 0.0 0.0 0.1 0.3 1 4.0 
C6 0.0 0.0 0.0 0.1 0.3 1 
Table 17 – Relative importance of criteria 
Finally, the fully ranking of all the four alternatives was found by the software at 460th 
answer (85% of 540 potential questions).  
3.1.4 Discussion and conclusions 
The results show that the Alternative A2 (weighting 68.8%) represents the best solution for 
the ASL, followed by the Alternative A1 (current situation, 60.8%) and the Alternatives A3 and 
A4 (both 28.2%). Indeed, the A2 scenario represents the best compromise between the levels 
identified by decision makers for each scenario and their preferences selected during the 
assessment. 
Furthermore, the most important aspect to be considered is the supervisory capacity of the 
administration (Figure 8Ȍ. This result underlines the policy makersǯ awareness of the importance 
of implementing a structured policy, closely related to quality improvement of service and long-
term cost saving. This fact is confirmed by the high weights assigned to C2 ȋǲEffects on the organization: work processesǳȌ and C4 ȋǲQuality of provided servicesǳȌ criteria. It represents a 
strong long-term perspective, in which it is better to make high investment at the beginning, in 
order to achieve more durable and high-quality results. 
The application of the PAPRIKA method for redesigning the Clinical Engineering Service in 
compliance with national and regional requirements for hospital accreditation can be considered 
successful.  
Indeed, it has been possible to identify the best scenario (A2), according to the most important criteria selected by decision makersǯ, and underline the path to be followed by the 
Organization, defined by the resulting criteria scores. 
The selected Scenario allows the CES to adopt, on a case-by-case basis, the solution that 
guarantees the best quality and the patient safety. It is also the Scenario with the highest level of 
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C3 ȋǲSupervisory capacity of the administrationǳȌ and C4 ȋǲQuality of provided servicesǳȌ, 
considered among the most important aspects by decision makers. 
On the other hand, through the adoption of the Alternative 2, the emergency and urgent 
resolution can be improved by applying the a priori identification of the equipment classes most 
susceptible to breakdown, in order to make replacement devices available in case of need. 
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3.2 Process improvement of Sterilization Services 
In line with the overall study, that aims to find methods and approaches for improving the 
healthcare domain in different areas, this section is specifically dedicated to the process for 
managing surgical tools, with particular attention to Sterilization Service. The study assesses the 
current sterilization service of an Italian hospital, proposing a reorganization of the current 
solution through different techniques currently used within process management, in order to 
improve the sterilization service.  
Particularly, the study exploits lean management that constitutes an emerging approach in 
the healthcare context, in order to increase quality of care and reduce costs. Nevertheless, 
literature shows the lack of a standardized method for applying lean techniques, especially in 
healthcare, due to the complexity of the involved processes. 
Specifically, this section proposes an innovative method for standardizing the lean 
management approach in healthcare, in order to reduce wastes in hospitals. The integration of 
different techniques (i.e., IDEF0 and GQM), generally used in process management is proposed, 
in order to let the overall method reproducible and repeatable. The application and feasibility of 
the method has been studied in an Italian hospital, in the specific context of Sterilization Service, 
since it subtends some core activities within hospitals. 
3.2.1 Introduction 
Lean principles have been worldwide used in the service industries, in order to reduce 
wastes (muda), improve processes, increase quality of services, and decrease costs. Lean 
management was introduced for the first time in the manufacturing sector (Toyota) [173], and it 
has been successful in waste reduction of the production process, delivering high-quality 
products. Its success has been proved in the automotive and electronic fields [174], too. 
In the last decade, lean has been applied also in healthcare services that significantly need of 
improvement in the domains of safety, effectiveness, timeliness, and appropriateness of care 
services [175], representing one of the most considerable trends in service industry [176]. 
Moreover, the improvement of care processes, which represents another direct consequence of 
the lean management implementation, produces reduction of costs and the consequent 
resources reallocation. 
Several worldwide healthcare organizations are currently using lean approach. 
Nevertheless, a standardized method has not been yet defined, coherently with the lean 
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management historical evolution (initial lack of written procedures for describing the method) 
[177]. 
Furthermore, the implementation of lean as a systematic approach in hospitals is not easy, 
due to the complexity of the care processes, the stakeholders involved [178], the specific needs 
and different cultures [179] of organizations. Moreover, one of the most challenging goals the 
healthcare systems have to deal with is the rapid growing and acquisition of new technologies 
[180]: people involved in the processes have to be continuously trained, and Standard Operating 
Procedures must be frequently updated. Another crucial aspect to be considered is the resistance 
of operators to management changes, anytime a new process or technology is introduced. 
For these reasons, hospital must be considered as a complex dynamic environment, and the 
introduction of a systematic approach must be studied and assessed carefully. 
In order to add value to an organization, it is essential to identify and eliminate waste, 
starting from the analysis of processes. The lean tool used for this purpose is the Value Stream 
Map (VSM), a method for analyzing the current state (Current Stream Map) and designing a 
future state of a process (Future Stream Map). Nevertheless, the literature shows that some of 
the metrics used in the VSM lack of a unique definition, especially in the healthcare context. This 
makes difficult to compare different studies in the literature, and to evaluate clearly the actual 
improvements of the organization following the lean techniques application. Indeed, the goal of a 
metric should be obtaining objective, reproducible and quantifiable measurements, but this goal 
is not always reached, due to differences in the definitions of VSM metrics available in the 
literature. 
In order to measure properties of software and its specifications, in the computer science 
context many software metrics ȋe.g., (alstead Complexity, DSQ), Robert Cecil Martinǯs software 
package metrics, Goal Question Metric) have been used. Particularly, Goal Question Metric (GQM) 
[181] is used to gather the measurement data and drive decision making and improvements, 
providing a support for identifying metrics starting from the definition of goals. 
On the other hand, different functional modeling methods (e.g., function block diagram, 
HIPO and IPO, N2 Chart, IDEF0) are available in system engineering and they can be used as a 
support to the Value Stream Mapping. Particularly, IDEF0 is sometimes used as a support of lean 
management, since it allows mapping and analyzing complex interactions of a system [182]. 
In this section, a standardized method, based on lean principles, supported by IDEF0 and 
GQM that can be used in any manufacturing and healthcare context is presented. Moreover, the 
problem related to the lack of mathematical formula for defining some metrics used in the VSM is 
faced and a solution is proposed. 
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3.2.2 Material and methods 
Lean Thinking and Lean wastes 
The main purpose of lean management is to create value for the end customer, through the 
elimination of wastes. Its philosophy derives mostly from the Toyota Production System (TPS), 
and it is focused on reduction of the original Toyota seven wastes (briefly described in Table 18) 
to improve overall customer value. Some other wastes have been added later on from other 
researchers, even though they have not been universally accepted [183]. 
The Value Stream Map is the lean management tool for mapping the actions of the actors 
involved in a process. It employs standard symbols to represent items and processes, and key 
metrics are associated with each phase of the described process. 
Moreover, different tools are currently used and integrated at TPS operational level, such as 
Total Quality Management for assessing quality, Theory of Constraints for identifying constraints and restructure the rest of the organization around it, Six Sigma ȋ͸σ) and Statistical Process 
Control for assessing the variability of a process. Even though it is not yet a common and shared 
approach, a recent study [184], proposed the application of lean systems approaches to health 
technology assessment, in order to create real incentives for innovation and value creation.  
 
Type of waste Brief Description Example in healthcare context 
Defects Time spent doing something incorrectly, inspecting 
for errors, or fixing errors 
Surgical case cart missing an item 
Overproduction Doing more than what is needed by the customer or 
doing it sooner than needed 
Performing unnecessary diagnostic 
procedures 
Transportation Unnecessary movement of the product in a system 
(patients, specimens, materials) 
Poor layout, such as the sterilization service 
being located a long distance from operating 
theatre 
Waiting Waiting for the next event to occur or next work 
activity 
Patient waiting for an appointment 
Inventory Excess inventory cost through financial costs, 
storage and movement costs, wastage 
Expired supplies that must be disposed of, 
such as out-of-date medications 
Motion Unnecessary movement by employees in the system Lab employees walking miles per day due to 
poor layout 
Overprocessing Doing work that is not valued by costumers, or 
caused by definitions of quality that are not aligned 
with patient needs 
Time/date stamps put onto forms, but the 
data are never used 
Table 18 – Types of waste (Modified by [185]) 
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IDEF0 
The IDEF0, a part of the IDEF family of modeling languages of software engineering, is a 
function modeling methodology that provides a representation of a process, combing texts, 
diagrams and graphic, detailing information about the input and output of an activity, how that 
activity is controlled, and the involved resources and mechanisms. It results in a hierarchical 
description that shows the links among the activities. The overall description of the process can 
be specified according to the level of the description needed by the organization, or the 
complexity of the process itself. 
GQM 
The Goal Question Metric is a measurement system that can be divided into three levels: 
 Goal (Conceptual level): it defines the main purposes of a work to be measured; 
 Question (Operational level): it defines a set of questions useful for achieving the goals; 
 Metric (Quantitative level): it defines a set of metrics for answering the questions in a 
measurable way. 
The overall GQM diagram is shown in Figure 9. 
 
 
Figure 9 – GQM overall diagram 
3.2.3 Standardizing lean approach 
The representation of lean approach standardization, proposed in this study, is presented in 
Figure 10. In order to improve an activity in accordance with lean-thinking, an analysis of the 
overall process must be addressed. A team-leader must be identified for getting guidance and 
suggestions on directions. The team leader should have the capability to work in a multi-
disciplinary team, for interacting with people with different backgrounds. She/he should also 
Question 1 Question 2 Question 3
Goal 2Goal 1
Metric 1 Metric 2 Metric 3
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have an engineering background, for providing systematic and precise instructions to the team, 
in order to design and describe the process. Moreover, she/he should know and understand the 
healthcare environment as well as the most common related issues. This is the reason why 
clinical engineering has also being involved in this field. 
IDEF0 can be used to describe the process and identify the most problematic areas and the 
inter-relations among different activities. This phase must be addressed with the contribution 
provided by the actors involved in the process, who can describe the actual problems and, 
consequently, the real improvement areas. The team-leader must follow personally the process, 
in order to gain an external perspective of the main problems associated. 
For identifying measurable metrics, the support of GQM can be valuable. Since the main goal 
of the lean-management is to reduce wastes, the reduction of mudas selected by the organization 
can be set as the Goals in the GQM. Questions must be found in order to reduce the wastes 
identified in a process, and measurable metrics (described through mathematical formula) must 
be defined. 
The Current Stream Map, required by lean philosophy, can be designed by summarizing the 
most important phases of the process to be improved and selecting the metrics, identified 
through GQM and included in the data box. Through the analysis of the collected data, 
improvement solutions based on lean-techniques (e.g., Work Standardization, Poka-Yoke, 
Kanban, Spaghetti Diagram) can be implemented, and the Future Stream Map can be designed. 
 
 
Figure 10 – Diagram block describing the proposed method for standardizing lean approach 
Through the comparison between the metrics of the Current and the Future Stream Maps, 
the improvements of the process can be monitored during the time. 
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Case study 
In order to evaluate the described method, it was tested in the Operating Theater and 
Sterilization Service of the Italian Hospital F. Miulli. Particularly, the surgical tools process was 
studied. The criteria used for selecting this process among the others were related to the 
importance of the activity in a core process, the arising attention on the matter by the 
international patient safety organizations (e.g., JCI), and the complaints related to the surgical 
tools the top managers have been received from clinicians and nurses working in the Operating 
Theater. Preliminary, informal interviews were made with the actors involved in the process, 
and the professionals who wanted to give a support to improve the process were selected as part 
of the team. The survey was designed as in Figure 11. 
 
 
Figure 11 – Survey set-up representation 
2. Data collection tools design
1. Overview
1.1 Understanding the process
Written procedures
1.2 Identification of involved actors
Inverviews with managers of the service
1.3 Preliminary observations
Observation, non-structured interviews
2.1 Target identification (Conceptual Level)
Written procedures, preliminary observation, GQM
2.2 Questions identification (Operational Level)
Written procedures, preliminary observation, GQM
2.3 Metrics identification (Quantitative Level)
Written procedures preliminary observation, GQM
2.4 Data collection tool implementation
Structured tools for monitoring
3. Data collection
3.1 Data collection through implemented tools
Structured tools for monitoring, observation
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The surgical tools process was described, both for the activities performed in operating 
theatre and central sterile services department, with IDEF0 (Figure 12 and Figure 13), and 
detailed descriptions were made with respect to the most precarious activities (i.e., methodology 
for preparing the surgical tools containers, number and typology of surgical tools prepared 
before surgical operations, nonconformities). Particularly, ǲnonconformitiesǳ refer to defects 
that deviate from standards defined by quality regulations. 
 
Figure 12 – Representation through IDEF0 of surgical instruments process within the Operating Theatre (OT: Operating 
Theatre, OR: Operating Room) 
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Figure 13 – Representation through IDEF0 of surgical instruments process within the Central Sterile Supply Department 
(CSSD: Central Sterile Supply Department, SW: Itineris, Software currently in use) 
The reduction of the seven muda (aggregated in 6 goals in Figure 14), was set as goals in the 
GQM. As detailed in Figure 14, fifteen questions were identified and seventeen metrics were 
defined. 
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Figure 14 – Description of Goals (wastes to be reduced), Questions and Metrics identified for improving the process 
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G3 – Transportation 
and Motion
G4 – Overprocessing
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available in the operating room?
Q7 – Does the equipment work 
properly?
Q8 – How many transportations 
of surgical tools are performed 
during surgical operation?
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for transportations?
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Q11 – Is transportation of charts 
performed properly?
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For each metric included in the study, a description together with mathematical formulas 
was provided (Table 19, related to Operating Theatre and Table 20 related to Central Sterile 
Services Department).  
Particularly, regarding operating theatre activities, s is defined as s-th transportation of the 
S total transportations, where Ͳ ≤ ݏ ≤ ܵ, ti and tf are initial and final time respectively of each 
step of the process, where: ݐ଴ < ݏݐ݁ݎ�݈݁ �݊ݏݐݎݑ݉݁݊ݐ ݐܾ݈ܽ݁ ݌ݎ݁݌ܽݎܽݐ�݋݊ < ݐଵ ݐଶ < ݏݐ݁ݎ�݈݁ �݊ݏݐݎݑ݉݁݊ݐ ݑݏܽ�݁ < ݐଷ ݐସ < ݌݋ݏ�ݐ�݋݊�݊� ݑݏ݁݀ ݏݑݎ��݈ܿܽ �݊ݏݐݎݑ݉݁݊ݐ ݋݊ ݐℎ݁ ܿܽݎݐ < ݐହ ݐ଺ < ݐݎܽ݊ݏ݌݋ݎݐܽݐ�݋݊ ݐ݋ ܵݐ݁ݎ�݈�ݖܽݐ�݋݊ ܵ݁ݎݒ�ܿ݁ < ݐ଻ 
Metric for VSM Tag Definition Formula 
Observation N Total number of observations  
Cycle Time CT Cycle Time: average time for completing an activity of the 
process, being N the total number of observations, tin and 
tfn the initial and final time of the n-th  activity, respectively 
ܥܶ = ͳܰ ∑ሺݐ௙௡ − ݐ�௡ሻே௡=ଵ  
Transportation ܵ̅ Average number of transportations within any single step 
of the process, due to the necessity of finding and moving 
surgical tools not available in the operating room 
ܵ̅ = ͳܰ ∑ ܵ௡ே௡=ଵ  
Transportation 
Time 
ݐ௦̅ Average time of the s-th transportations for finding and 
moving needed surgical tools in the operating room ݐ௦̅ = ͳܵ ∑ ݐ௦ௌ௦=ଵ  
NVA Time NVA Not Value Added: time spent in avoidable tasks (e.g., 
avoidable transports made by the operators looking for 
needed surgical tools not available in the Operating 
Rooms) 
S is the total number of transportations, and  t̅s is the 
average time of transportations 
ܸܰܣ = ܵ ∙  ݐ௦̅ܰ  
VA Time VA Value Added: time spent for add-value tasks of the process, 
defined as  
difference between the Cycle Time and the Non-Value 
Added time 
ܸܣ = ܥܶ − ܸܰܣ 
Uptime %  Percentage of the process (or part of the process) that 
brings only added value % ܷ݌ݐ�݉݁ = ܸܣܥܶ ∙ ͳͲͲ 
OST -- Opened Surgical Tools: number of ǲopenedǳ ȋnot anymore 
sterile) surgical tools, at the end of the process  
UST -- Used Surgical Tools:  number of surgical tools ǲusedǳ in a specific phase of the 
process (e.g., number surgical tools positioned on the 
surgical table within the first phase, number of surgical 
tools used for surgical operation within the second phased, 
etc.) 
 
Utilization -- Percentage of surgical tools used in a specific phase of the 
process % ܷݐ�݈�ݖܽݐ�݋݊ = ܷܱܵܶܵܶ ∙ ͳͲͲ 
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Metric for VSM Tag Definition Formula 
NC -- Average of Non Conformities detected in a specific phase of 
the process % ܰܥ = ܰ௪�௧ℎ ே�ܰ ∙ ͳͲͲ 
Availability -- Prompt availability of surgical tools needed for completing 
a specific phase of the process (e.g., availability of surgical 
case cart (SC) or surgical kit (SK) directly in the operating 
room (OR) within the first phase, availability of 
transportation cart for moving used surgical tools to 
sterilization service within the third phase) 
% ܣݒܽ�݈ܾܽ�݈�ݐݕ= ∑ሺܵܥ + ܵ�ሻ�௡ ைோ∑ሺܵܥ + ܵ�ሻ௡௘௘ௗ௘ௗ ∙ ͳͲͲ 
Table 19 – Description of the Metrics used in the Value Stream Map of surgical tools in the Operating Theatre 
Regarding Sterilization Service activities, k is defined as k-th surgical kit studied during 
observation and data collection, where Ͳ ≤ ݇ ≤ �, ti and tf are initial and final time respectively 
of each step of the process, where: ݐ଴ < ܿℎ݁ܿ݇ − �݊ < ݐଵ ݐଶ < ℎܽ݊݀ ݓܽݏℎ�݊� < ݐଷ ݐସ < ܽݑݐ݋݉ܽݐ�ܿ ݓܽݏℎ�݊� < ݐହ ݐ଺ < ܽݏݏܾ݈݁݉�݊� ܽ݊݀ ݌ܽܿ݇ܽ��݊� < ݐ଻ ݐ଼ < ݏݐ݁ݎ�݈�ݖܽݐ�݋݊ < ݐଽ 
Metric for VSM Tag Definition Formula 
Kit K 
Total number of processed surgical kit in any single 
phase 
 
ST ST 
Total number of surgical tools available (not necessarily 
used) in any single phase) 
 
PST PST 
Processed Surgical Tools: number of surgical tools 
processes in any single phase 
 
CT/kit CTK 
Kit Cycle Time: average time for completing a single 
phase of the process, considering the kits processed in 
the Sterilization Service 
ܥ �ܶ = ͳ� ∑ሺݐ௙௞ − ݐ�௞ሻ�௞=ଵ  
CT/PST CTPST 
Single surgical tool Cycle Time: average time for 
completing a phase of the process, considering the total 
surgical tools processed within the single phase 
ܥ ௉ܶௌ் = ͳܲܵܶ ∑ሺݐ௙௞ − ݐ�௞ሻ�௞=ଵ  
Check ST 
% 
Check 
Percentage of kits where correspondence between 
intended and actual surgical tools was checked (either if 
output was positive or negative) 
 
MST  
Missed Surgical Tools: average number of missed 
surgical tools in any single kit where correspondence 
was checked 
 
Table 20 – Description of the Metrics used in the Value Stream Map of surgical tools in the Central Sterile Supply 
Department 
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Data related to twenty-three observations, one for each surgical operation, were collected 
within the operating theatre. Data related to thirty-nine kits and 1,937 surgical tools were 
collected within the sterilization service. 
The Current Stream Maps were designed for both the activities managed in the operating 
theatre (Figure 15) and the sterilization service (Figure 16), through the identification of the 
most important process activities and collected data were inserted into the data boxes, as 
discussed in the next paragraph. 
 
Figure 15 – Current Stream Map of surgical tools in the Operating Theatre 
 
Figure 16 – Current Stream Map of surgical tools in the Central Sterile Supply Department 
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3.2.4 Discussion and conclusions 
The analysis of collected data allowed the identification of the critical points of the process. 
Particularly, regarding activities in operating theatre, according to the metrics initially defined, 
critical points, as showed in Figure 15, were related to Utilization = 30.9 % at the Stage 1 and 
Stage 2 of the process; transportation time ݐ௦̅=5 minutes in Stage 1 and Stage 2 of the process; 
nonconformities = 47.8% and 75% during Stage 1 and Stage 3 of the process, respectively. 
Regarding sterilization department, the critical points, as showed in Figure 16, were mainly 
related to the lack of surgical tools checking during any phases of the process; the surgical tools 
over-processed during hand and automatic washing, since all surgical tools were completely 
processed even though they were not utilized during surgical procedures; and missed surgical 
tools not inserted in their package/case before sterilization. 
The process has been reviewed, the Future Stream Map was designed, the new process was 
simulated and the economic saving was calculated (see Table 21). 
Through some improvement activities, such as the inventory of surgical tools, and new 
definition of tools in the case/package, it is possible to increase the availability of the surgical 
tools, reduce the number of tools to be transported and to be processed by the Central Sterile 
Supply Department. From an economical perspective, an estimated hospital saving of 242,404 € 
(presented in Table 21) could be produced applying these improvements.  
Particularly, the redefinition of the storage areas and the application of both 5S (a lean 
method for organizing a work space for efficiency and effectiveness [186]) and Visual 
Management (a lean visual control method for increasing the efficiency and effectiveness of a 
process by making the steps in that process more visible [187]) may reduce the time spent for looking for the needed surgical tools ȋsaving estimated to be ͳ͵,ͲͲͲ €Ȍ. 
Furthermore, Cycle Time would be reduced of the 33% during the preparation of surgical 
tools, since less surgical tools would be positioned on surgical tools table, and the utilization of 
tools would increase of 70% (considering the availability of at least 30% tools to be used in case 
of emergency) and 45% (considering that surgical tools actually used would be, anyway, less than the ones prepared within the ǲbase-configurationǳ that excludes emergency situations) 
during the preparation of surgical case cart and the utilization phases, respectively. 
Finally, nonconformities would be reduced of 47% and 75% during the preparation of the 
surgical tools cart and the positioning of the tools on the cart, respectively. 
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Activity Unit cost Consequences 
Annual 
saving 
Census and redefinition of surgical kit ͷ,ͷͲͲ € 
Increased surgical tools availability ͳ͵,Ͳͺͺ € 
Less surgical tools to be processed 
within Sterilization Service 
ʹͲ͹,͵͵͵ € 
Elimination of washing activities within 
operating theatre 
ͻ,ͲͲͲ € 
Redefinition of surgical tools storage points 
within operating theatre and application of 5S 
and Visual Management 
ʹͺͲ € Reduction of time spent for looking for 
surgical tools 
ͳʹ,ͻͺ͵ € 
Total ͷ,͹ͺ0 €  2Ͷ2,Ͷ0Ͷ € 
Table 21 – Estimation of cost savings thanks to the implementation of the suggested activities aimed at reorganizing the 
process of surgical tools 
The application of the methodology was a useful support for the study and application of 
lean management techniques. The integration of IDEF0 and GQM facilitated the description of 
the process and identification of the metrics of interest. Indeed, structured metrics were 
provided and this makes possible the comparison between different studies. The proposed 
approach is versatile and it can be applied in any process or service, not only referred to the 
healthcare domain. Good results were achieved in terms of process efficiency, cost, cycle time, 
and nonconformity reduction. 
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3.3 HTA applied to hospital services through MCDA 
As already discussed, several authors acknowledged the complexities inherent in 
conducting HTA rapid reviews, suggesting that it is difficult to accomplish the triad of 
responsiveness to short timeframes, scientific rigor, and transparency in a manner consistently 
acceptable to all stakeholders [188]. However, despite these challenges, some HTA organizations 
reported producing a considerable number of rapid reviews [106]. ǲShort (TAǳ are then 
considered acceptable by both decision makers and scientific literature. Moreover, in those 
contexts where it is not easy to find comparative studies, due to lack of evidence in the literature, 
this is a useful starting point for defining structured approaches, based on scientific rigor, short 
timeframes, and usefulness from decision makers perspective. 
Particularly, hospital services should be assessed as well as other technologies are currently 
assessed through HTA, since they represent a crucial point for hospital and patients in terms of 
costs, efficiency, quality, and risk management. 
This section aims to apply the HTA approach to hospital services, considering the latter as 
technology assets of considerable importance within the healthcare domain. The study was 
conducted in within the Central Sterile Services Department (CSSD) of an Italian hospital. 
3.3.1 Introduction 
Perceived quality in healthcare is closely related to health system performances. Different 
frameworks for monitoring performance indicators are available in the literature and currently 
used in healthcare facilities, also driven by international organization for quality and patient 
safety (e.g., JCI) and quality regulations and standards. Before monitoring ongoing results in 
order to evaluate trends of healthcare facilities, it is important to gain insight into determinants 
that may facilitate or impede the introduction of innovations [189], and to carefully assess new 
processes, services or, more generally, technologies to be adopted in order to improve 
healthcare provision. As already discussed, HTA does not have a precise and standard definition, 
and its actual contents may vary in different application contexts [190]. Although the main steps 
of HTA have been identified, as reported by [191], the dimensions ȋor ǲdomainsǳ as defined by 
EUnetHTA) included in practical assessments often differ. Indeed, dimensions included in HTA 
are slightly different among national and international societies. For example, the Health 
Technology Assessment international (HTAi) society focuses on clinical, economic, 
organizational, social, legal and ethical issues; the WHO focuses on social, economic, 
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organizational and ethical issues; the Italian Agency for Regional Health Services (Age.Na.S.) 
focuses on effectiveness, safety, costs, and social-operational issues.  
The reason behind the absence of a harmonized definition may be related to different 
reasons, such as the stakeholders commissioning the assessment (macro-decision makers, e.g., 
governments and health ministries; meso-decision makers, e.g., hospitals and community health 
agencies; micro-decision makers, e.g., clinicians, patients [192]), the peculiarities of specific 
contexts and the peculiarities of health technologies. This last aspect deserves particular 
attention, as the term ǲ(ealth technologyǳ subsumes a wide range of technologies. In fact, health 
technology has been defined as the ǲapplication of organized knowledge and skills in the form of 
devices, medicines, vaccines, procedures and systems developed to solve a health problem and improve quality of livesǳ [193], or ǲdrugs, devices, and medical and surgical procedures used in medical care, and the organizational and supportive systems within which such care is providedǳ 
[194]. Scientific papers and national guidelines on HTA [195] mainly confine their attention to 
those technologies that directly involve patients (such as medicines, medical devices, and 
surgical procedures). Along the same lines, available HTA reports are primarily focused on the 
direct (potential) effects of the technology on patients, who are considered key stakeholders in 
the decision making process [196]. The interest toward this kind of technologies may be also 
induced by standards and regulations mandatorily required for both medical devices and drugs 
before their admission into the market, as well as the growing consideration of the best practices 
in patient pathways. Conversely, hospital services have received little attention in the HTA 
literature, even if, in many cases, they have non-negligible indirect impacts on patients. Such 
considerations have been remarked in recent studies;  in particular, the recent Clinical Engineering (andbook has introduced the concept of ǲhealth technology assets, such as medical 
devices and supplies; physical infrastructure, such as health buildings and associated services 
and utilities; and logistics support and information systemsǳ [8]. 
Consequently, even if hospital services can be included among the health technologies 
within HTA, its actual application might be problematic due to the lack of information of state-of-
the-art scientific findings, the difficulty to compare the available data and to devise standard 
methods that are capable to consider both the best practices and the peculiarities of each 
context. 
However, some of the still open challenges of the application of MCDA in HTA regard the 
identification and definition of the criteria to include in the assessment, and how to select 
criteria that are worldwide recognized as important. This problem is even more difficult for 
health technology assets, as hospital services, since the available literature is lacking. Some 
studies that investigated solutions to the reduction of expenditure and process improvement are 
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available in the literature. Particularly, MCDA has been used for assessing hospital services, such 
as Clinical Engineering Service [166] and Central Sterile Services Department (CSSD) [197]. 
Those studies emphasize the practical difficulties that are met in the case of complex services, 
whose assessment require to consider technical, economic and organizational aspects. A case in 
point is the assessment of different solutions for the CSSD, which constitutes a valid test case for 
MCDA application. 
CSSD is defined as a technical support unit, whose purpose is to provide appropriately-
processed medical-hospital articles, thus providing conditions for direct attendance and health 
care provision for ill and healthy individuals [198]. Indeed, CSSD plays a crucial role in hospital 
settings, since it provides tools and medical devices that must be properly sterilized, assuring the 
appropriate quality of medical care [199]. Actually, besides adverse events for patients, defects 
in sterilization can lead to heavy economic burden [200].  
CSSDs can be considered as hybrid systems, since they include not only products (e.g., 
medical device, supplies), but also structures, work processes, and organizational aspects that 
have to be carefully assessed and monitored for assuring good quality of service. CSSD must 
comply with national and international standards, as well as quality and safety requirements 
defined at different levels and that can depend on the specific health care system. However, 
hospitals are usually allowed to implement different organizational configurations of the service, 
internal, outsourced or mixed [197], according to their strategic goals, preferences, external 
constraints and opportunities. 
On the grounds of the previous considerations, the present study aims to answer the 
following research question: is it possible to find a generalized method for assessing hospital services, integrating international expertsǯ know-how and specific needs at a local level? In order 
to address this question, an assessment methodology, based on the concepts of HTA and 
supported by an MCDA method, was devised and applied to an Italian case study. 
3.3.2 Methodology 
The proposed methodology is performed in several steps, some innovative, which aim to 
involve both international and national panels of experienced professionals, and other that 
represent a combination of some of the available paths described in the literature concerning 
HTA and MCDA (e.g., [201], [202], [203]). 
 
A workflow of the assessment process is shown in Figure 17 and its main steps are 
summarized in the following numbered list: 
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1. Identification of the decision goal 
2. Identification of the alternative technology assets (alternative services) 
3. Decomposition of the decision objective into evaluation dimensions   
4. Definition of the criteria (such as properties, measures of performance, etc.) of interest 
for each dimension 
5. Selection of the most important criteria for each dimension, which will be used for the 
assessment (international level) 
6. Assessment of the alternative services on the  selected criteria (local level) 
7. Calculation of group judgments and overall performance of the alternatives (local level). 
 
 
Figure 17 – Workflow of the assessment process 
Identification of decision 
goal
Identification of the 
alternative technologies
Decomposition of the 
decision objectives into 
evaluation dimensions
Definition of the criteria of 
interest for each dimension
Selection of the most 
important criteria for each 
dimension 
(INTERNATIONAL PANEL)
Set-up of the MCDA tool to 
be used
(LOCAL LEVEL)
Assessment and overall 
performance of the 
alternatives 
(LOCAL LEVEL)
Brainstorming session
Criteria refined to let 
them unambiguous, 
comprehensive, direct, 
operational, 
understandable
Design of the survey
Identification of 
channels for involving 
experts in the field (e.g., 
LinkedIn)
Collection of data
Analysis of results and 
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The method was applied to the )talian local health authority of Matera ȋǲASMǳȌ, in Basilicata 
Region. The ASM comprises five hospitals. Among these, three hospitals perform surgical 
activities, for a total of 392 ordinary beds, 90 Day Hospital beds, 15 operating rooms, 13,000 
surgical operations in 2015. The current sterilization service is mixed, since some of the 
activities are outsourced to external companies. However, the ASM owns proprietary systems, 
technologies and surgical tools. 
A detailed description of the steps of the methodology is provided below. 
First of all (step 1) it is necessary to identify the technology to be assessed. In healthcare 
services, the technology asset may be a hospital service that has to be renewed due to different reasons, such as indirect hazardous consequences related to the service ȋe.g., increasing patientsǯ 
infections due to incorrect surgical tools sterilization), costs unsustainability, introduction of 
new hospital strategies (e.g., investment on innovative technologies). 
At the ASM, the CSSD has currently a mixed management. As already mentioned, the ASM 
comprises several hospitals, which became part of the ASM in different times and whose CSSDs 
were structured and managed differently (internal, mixed and outsourced services). The 
outsourced activities of the CSSDs are managed by a unique provider. The contract with this 
provider will expire soon, and this represents an opportunity to perform a reconfiguration of the 
whole CSSD. 
For healthcare services, it is possible to identify alternative solutions (step 2) by taking into 
consideration the opportunities that are actually offered by the market, or by devising 
technically feasible but not ready-made solutions. This second avenue can be useful to detect the 
expected features and performance of the service for the specific hospital, which could form the 
basis of a competitive tender when this is required. The outputs of the application of the whole 
method by choosing the latter approach may be also of use by the specific hospital in terms of 
explicating healthcare needs, and it may serve as an important driver for claiming specific 
requirements to outsourced companies or to stakeholders at a macro level. 
The alternatives identified by the ASM are based on their previous experiences and the 
current offers made by external providers. All the alternatives comply with regulations and 
standard requirements (e.g. concerning safety). Particularly, the three alternatives are defined as 
follow: 
A1. )nternal service: all the reprocessing and sterilization phases are handled ǲin houseǳ, 
involving internal staff and using (already) proprietary systems, technologies and surgical tools; 
A2. External service: all the reprocessing and sterilization phases are handled through 
external resources. Staff, systems, technologies and surgical tools are outsourced to external 
companies; 
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A3. Mixed service: staff involved in the reprocessing and sterilization phases, including 
logistic, are outsourced to external companies. Systems, technologies and surgical tools are 
(already) proprietary. 
Step 3 regards the identification of the dimensions of interest. As already mentioned in the 
Introduction section, the properties to be assessed may differ according to different kinds of 
technologies and contexts of application. Among all the dimensions currently in use for assessing 
health technologies, we propose the following: effectiveness/technical properties (T), 
organizational properties (O), safety (S), and economic (E) dimensions. 
Technical properties, including ǲperformance characteristics and conformity with 
specifications for design, composition, manufacturing, tolerances, reliability, ease of use, maintenance, etc.ǳ [191], may be better defined as ǲoperational effectivenessǳ in the specific 
context of hospital services, thus including effectiveness, as another property frequently used in 
HTA. Specifically, operational effectiveness aims at better utilizing the organizationǯs available 
resources, better implementing its processes and better accomplishing its goals. Nevertheless, in 
this specific context we refer it only to devices and structures within the service. 
Organizational properties embrace both management issues, related to the planning and 
organization of the healthcare service, and the personnelǯs soft skills. Typically, the aspects most 
frequently used within this dimension are education, skills and centralization/decentralization 
[204]. 
Widely used within (TA, safety can be defined as ǲjudgment of the acceptability of risk 
associated with using a technologyǳ. 
The abovementioned four dimensions are general and comprehensive, and they can be, 
anyhow, shaped on the specific context, including different kinds of properties according to the 
characteristics of the service.  
Step 4 concerns the definition of criteria of interest for each dimension. The aim of this step 
is to identify a comprehensive list of criteria related to the healthcare service to be assessed, at 
international level.  
In our case study, a brainstorming between professionals working at the ASM was 
performed. Specifically, the professionals involved were: 1 clinical engineer specialized in health 
technologies, 1 clinical engineer specialized in provisioning, 1 engineer specialized in 
management, and 2 healthcare professionals working at the CSSD. Each participant performed a 
brief state-of-the-art review concerning indicators to be considered for guaranteeing a good 
quality of CSSD (e.g., [200], [205], [206]). During the brainstorming, the professionals debated 
together on both the literature and their perspective. This activity resulted in a first list of 
criteria. Then, criteria definitions were refined, in order to let them unambiguous, 
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comprehensive, direct, operational, understandable, as defined by [207] as the main properties 
for a good attribute. 
At the end of step 4, the following criteria were identified: 
 For the effectiveness/technical dimension: structure management; operational and 
technological level; characteristics of structures and installed equipment; surgical 
tools updating; process productivity; lead time of surgical tools; other. 
 For the organizational dimension: possibility to recruit other staff; supervision and 
management competences; operational competence; organization flexibility; 
management of unplanned situations; coordination and organization synergy; other. 
 For the safety dimension: responsibility of Quality Controls; service provider lock-in; 
clinical risk management; technological adjustment; other. 
As for the economic dimension, only the total costs of each alternative was taken into 
consideration, as these data were readily available for all solutions. 
The most important criteria were selected by an international panel (step 5). This step was 
divided into 4 tasks: 
a. Design of the survey. The survey questionnaire was divided into the dimensions 
previously determined. For each dimension, all the identified criteria were listed, together with the editable field ǲotherǳ. The questionnaire was designed and 
administered through SurveyMonkey, a free web-based tool that allows developing 
customizable surveys. Respondents were asked to rank the criteria according to their 
importance (from the most to the less important). A short description of each criterion 
was provided in order to ensure that respondents understood their meaning. Moreover, 
to verify that panel members were representative of the target population, some 
preliminary questions, related to their professional background, were inserted. 
b. Identification of channels for involving experts in the field. In addition to dedicated 
associations and societies devoted to the field of interest, one of the easiest ways for 
reaching international experts may be through LinkedIn. Moreover, LinkedIn Groups 
often gather professionals who enjoy being part of the online community and they may be interested in providing their support as ǲhelpersǳ, as defined by [208]. Furthermore, 
web-based surveys have been proven to be more reliable compared to telephone ones 
[209]. In our case study, the web link to SurveyMonkey was posted on the following Linked)n groups: ǲDecontamination Sciences & Sterile Services Personnelǳ, ǲSterilization of Pharmaceuticals, Medical Devices & Biological Materialsǳ, ǲSVN-Sterilisatie Vereniging Nederlandǳ, ǲSterile Processing Department Professionalsǳ.  No individual invitations 
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were made, but a single call accompanied the public post. No rewards were foreseen for 
completing the questionnaire. 
c. Collection of data. After a preliminary test, the survey questionnaire was posted on the 
abovementioned LinkedIn Groups. Data collection lasted 1 month. 
d. Analysis of results and selection of criteria to be included in the MCDA model. In order to aggregate the respondentsǯ judgments and obtain the overall level of importance of every 
criterion, it was necessary to convert the rankings into cardinal values. To this end, the 
rank ordered centroid (ROC) was employed, as it provides a reliable transformation 
when compared to other methods and it has been demonstrated to weight more 
accurately than the other rank-based formulae [210]. In summary, the application of ROC 
produced the ranking of all the criteria of a dimension, taking into account the respondentsǯ judgments. Eventually, in order to ensure a balanced contribution of all the 
dimensions of interest to the assessment, it was decided to select the first two criteria in 
each ranking for the final steps of the methodology. 
Step 6 concerns the set-up of the MCDA tool to be used. A key advantage of MCDA in HTA is 
its ǲease of useǳ, one of the most important characteristics for a tool to be actually used in 
practice. In this respect, among the available MCDA methods (e.g., AHP [211], ELECTRE [212]), 
PAPRIKA [168] is very intuitive and easy-to-use, even by decision-makers or assessors with 
limited knowledge of MCDA, and therefore could be the right choice in the case study. The set-up 
was made directly through ǲͳͲͲͲmindsǳ, an on-line tool made available by the authors of the 
method. The criteria selected in the previous step were validated by a clinical engineer, who also 
defined the possible levels of preference. Particularly, for each of the six selected criteria (two for 
each dimension) and the criterion representing the economic perspective, three different 
qualitative or quantitative levels of preferences were defined (Table 22). The levels vary from L1 
(worst option) to L3 (best option).  
A clinical engineer of the ASM, who possesses transversal skills, was required to assess the 
alternatives against each criterion using the proposed levels of preference.  
In the last step 7, decision makers of the local health authority were required to perform 
pairwise comparisons through the PAPRIKA tool. In the case study, the local panel was 
composed by 6 decision makers, working at the ASM, with the following positions: director of 
clinical engineering service, chief medical officer, hospital risk manager, procurement officer, 
operating theater director, chief business officer. A precise explanation of qualitative values meaning was written in participantsǯ mother tongue and provided to respondents. The weights 
(levels of importance) of the criteria, as well as the final ranking of the alternatives, were 
produced by 1000 minds as a result of the answers provided during the pairwise comparisons. 
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ID Dimension Criterion Level Value 
C1 Organizational 
Supervision and 
management 
competences 
L1 Poor 
L2 Medium 
L3 High 
C2 Organizational 
Operational 
competence 
L1 Poor 
L2 Medium 
L3 High 
C3 
Effectiveness / 
Technical 
Structure 
management 
L1 Mean Time To Repair < 1working hour 
L2 Mean Time To Repair between 1 and 8 working hour(s) 
L3 Mean Time To Repair > 8 working hours 
C4 
Effectiveness / 
Technical 
Operational and 
technological level 
L1 Up-Time < 95% 
L2 Up-Time between  95% and 99% 
L3 Up-Time > 99% 
C5 Safety 
Responsibility of 
Quality Controls 
L1 Poor 
L2 Medium 
L3 High 
C6 Safety 
Clinical Risk 
Management 
L1 Poor 
L2 Medium 
L3 High 
C7 Economic Total cost 
L1 More than ʹ,ʹͲͲ,ͲͲͲ € 
L2 Between ͳ,ͺͲͲ,ͲͲͲ € and ʹ,ʹͲͲ,ͲͲͲ € 
L3 Less than ͳ,ͺͲͲ,ͲͲͲ € 
Table 22 – Criteria selected for the study with corresponding preference levels. Before starting the assessment, the 
meaning of values was carefully explained to the respondents 
3.3.3 Results 
From April 2016 to May 2016, 53 filled questionnaires were collected: 27 respondents 
(50.9%) fully or partially completed the questionnaire. Only 19 fully completed questionnaires 
(35.8%) were selected within the international panel as the respondents met the following pre-
requisite: the international panel is a multidisciplinary and internationally group of 
professionals working in the field of sterilization process with at least 3 years of experience + 
certification in the field (e.g., Certified Sterile Processing and Distribution Technician - CSPDT, 
Certified Registered Central Service Technician - CRCST, Certified Instrument Specialist - CIS) or, 
since certification system is not offered in all the Countries, professionals with at least 10 years 
of experience in the field. The years of respondentsǯ experience (average 16.68 years) and the 
number of certified professionals are reported in Table 23. 
Of the 19 professionals within the international panel, 1 is from Indonesia, 1 from Canada, 4 
from the USA, 2 from Australia, 1 from New Zealand, 3 from the UK, 1 from France, 5 from Italy, 
and 1 from the Netherlands. 
Moreover, of the 19 professionals working within sterilization services, 2 are engineers, 7 
technicians/nurses, 1 biologist, 7 managers, 1 product specialist, and 1 pharmacist. 
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Working experience 
(years) 
Number of 
professionals 
N. of professionals 
holding 
certifications 
more than 30 2 2 
from 20 to 29 5 2 
from 15 to 19 4 2 
from 10 to 14 4 1 
from 3 to 9 4 4 
Total 19 11 
Table 23 – Short description of professionals included in the international panel 
The average time for completing the survey was ͳͳǯͶͳǯǯ ȋmin Ͷǯ͵ͳǯǯ, max ʹ͸ǯͷͲǯǯȌ. The results 
of the ROC analysis are reported in Table 24 for each dimension. 
 
ID New ID Criteria Sum Mean 
O.1  Other staff recruitment 2.37 0.12 
O.2 C1 Supervision and management competence 4.68 0.25 
O.3 C2 Operational competence 3.93 0.21 
O.4  Organization flexibility 2.39 0.13 
O.5  Management of unplanned situations 2.47 0.13 
O.6  Coordination synergy 1.79 0.09 
O.7  Other 0.27 0.01 
T.1 C3 Structures management 4.23 0.22 
T.2 C4 Operational and technological level 4.00 0.21 
T.3  Characteristics structure/installed equipment 2.87 0.15 
T.4  Surgical tools updating 2.20 0.12 
T.5  Process productivity 2.47 0.13 
T.6  Lead time of surgical kit 2.63 0.14 
T.7  Other 0.45 0.02 
S.1 C5 Responsibility of quality controls 5.71 0.30 
S.2  Service provider lock-in 2.61 0.14 
S.3 C6 Clinical risk management 5.78 0.30 
S.4  Technological adjustment 4.14 0.22 
S.5  Other 0.48 0.03 
Table 24 – Weighted sum and mean of cardinal values obtained through the application of the Rank Order Centroid (ROC) 
method, within dimensions. The highest values of importance in each dimension are displayed in bold and new IDs (C1-C6) 
were assigned to the corresponding criteria 
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As described in the previous section, the first two criteria of each dimension (highlighted in 
bold in Table 24) and the criterion representing the economic perspective, were used for setting-
up PAPRIKA involving the local panel of professionals. 
The MCDA assessment model is made up of seven criteria (C1-C7) with three preference 
levels each (L1-L3). It is worth mentioning that the PAPRIKA method, combining the levels of all criteria, builds a set of ǲpotentialǳ alternatives, which are then pairwise compared by the 
decision-makers in order to obtain the overall priorities that will be assigned to the actual 
investigated alternatives [168]. In the specific case 37=2,187 combinations of the levels and an 
equal number of potential alternatives are possible. However, 1000minds software is able to 
reduce this number by eliminating the potential alternatives that are dominated by others 
during the interactive assessment process. In the case study, the average number of pairwise 
comparisons that were made by the six respondents of the local panel was 29.5 (min 23, max 40) 
and the average time needed for completing the assessment process was ͹ǯ ȋmin ͸ǯ, max ͻǯȌ. 
The median, mean and Standard Deviation of the obtained priorities, representing the 
relative importance (weights) of the criteria to the participants, are reported in Table 25 and 
radar chart of Figure 18.  
 
Criterion Median Mean 
Standard 
Deviation 
C1 18.0 % 18.2 % 3.1 % 
C2 18.4 % 17.9 % 2.5 % 
C3 12.2 % 11.3 % 4.5 % 
C4 11.0 % 9.8 % 4.5 % 
C5 17.9 % 16.1 % 6.8 % 
C6 15.9 % 16.6 % 6.3 % 
C7 10.6 % 10.1 % 6.2 % 
Table 25 – Median, mean and Standard Deviation of priorities 
Particularly, the weight of a criterion corresponds to the average priority obtained by the 
highest level of preference of that criterion. For example (see Figure 18), since the average 
priority (mean) of the highest levels C4 and C1 are 9.8% and 18.2% respectively, C1 is almost 
twice as important as criterion C4. 
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Figure 18 – Radar chart of weights. ǲCͷǳ: Supervision and management competence; ǲC͸ǳ: Operational competence; ǲC͹ǳ: 
Structures management; ǲCͺǳ: Operational and technological level; ǲCͻǳ: Responsibility of quality controls; ǲCͼǳ: Clinical 
risk management; ǲCͽǳ: Overall cost 
Moreover, the ǲMarginal Rate of Substitutionǳ ȋi.e., the rate at which the decision makers are 
ready to exchange an alternative for another one while maintaining the same level of utility) of 
the column criteria for the row criteria, is shown in Table 26. 
 
Marginal Rate of Substitution C1 C2 C6 C5 C3 C7 C4 
Supervision and management competence C1   1 1.1 1.1 1.6 1.8 1.9 
Operational competence C2 1   1,1 1.1 1.6 1.8 1.8 
Clinical risk management C6 0.9 0.9   1 1.5 1.6 1.7 
Responsibility of quality controls C5 0.9 0.9 1   1.4 1.6 1.7 
Structures management C3 0.6 0.6 0.7 0.7   1.1 1.2 
Overall cost C7 0.6 0.6 0.6 0.6 0.9   1 
Operational and technological level C4 0.5 0.5 0.6 0.6 0.9 1   
Table 26 –Relative importance of criteria (ratio between the weights of the row criteria to the column criteria) 
Table 27 shows in the last column the normalized attribute weights (Wi) and, in the fourth, 
the single attribute scores (Si), which correspond to the percentage of the contribution of a level 
in a criterion to the overall priority. In other words, the overall priority of an alternative (P) is 
calculated as: ܲ = ∑ ௐ�ௌ�ଵ଴଴� , where i = ͷ, …,  n (n, number of criteria) 
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All the six stakeholders of the local panel resulted to prefer CSSD internal service, followed 
by mixed service. The outsourced service was at the third and last position for all of the 6 
stakeholders. 
3.3.4 Discussion and conclusions 
The results of the preliminary stage of the study, focused on the scouting and identification 
of an international panel of experts, allowed to identify the main aspects to be considered for 
assessing a CSSD. Even though 19 professionals involved is a considerable number for the scope 
of the work, the low percentage of respondents who completed the survey, compared to the total 
amount of collected questionnaires (35.8%), may suggest that the definition of the criteria has to 
be further simplified. On the other hand, LinkedIn showed to be a good channel for easily 
reaching experts in the field of interest at international level. Indeed, LinkedIn will be also used 
for sharing results of the work, in order to facilitate the dissemination process as it is one 
important moment of HTA. 
ID Attribute Level 
Single attribute 
score (0-100) 
Attribute weight 
(sum to 1) 
C1 
Supervision and 
management 
competence 
Poor 0 
0.182 Medium 70.4 
High 100 
C2 Operational competence 
Poor 0 
0.179 Medium 83.5 
High 100 
C3 Structure management 
Mean Time To Repair < 1working hour 0 
0.113 Mean Time To Repair 1-8 working hour(s) 55.9 
Mean Time To Repair > 8 working hours 100 
C4 
Operational and 
technological level 
Up-Time < 95% 0 
0.098 Up-Time between  95% and 99% 67.9 
Up-Time > 99% 100 
C5 
Responsibility of Quality 
Controls 
Poor 0 
0.161 Medium 69.9 
High 100 
C6 
Clinical Risk 
Management 
Poor 0 
0.166 Medium 68.2 
High 100 
C7 Total cost 
More than ʹ,ʹͲͲ,ͲͲͲ € 0 
0.101 Between ͳ,ͺͲͲ,ͲͲͲ € and ʹ,ʹͲͲ,ͲͲͲ € 69 Less than ͳ,ͺͲͲ,ͲͲͲ € 100 
Table 27 – Normalized criterion weights and single criterion scores (means) 
 
 
HTA APPLIED TO HOSPITAL SERVICES THROUGH MCDA CHAPTER 3 
 
 
 
99 
 
At a local level, the application of the MCDA method using the previously selected attributes, 
allowed to identify the best solution among the stakeholders, through an easy-to-use and not 
time-consuming tool ȋ͹ǯ per person on average). All the stakeholders resulted to prefer the 
internal service, followed by mixed service and out-sourced one. Their preference is in line with 
the characteristic of the area: the ASM comprises 5 hospitals, and it covers a wide area (3.479 
km2), with a population density of 58 persons/ km2; the orographic distribution, together with 
road links, does not help a centralized management of patients and services. Moreover, an 
interesting result is related to the low weight given to the economic dimension. Indeed, since the 
current policy of different Italian Regions encourages hospitals to outsource non-core services, 
including CSSD, this might work as leverage for the hospital to claim an in-house CSSD. 
Nevertheless, the results might change if the methodology were employed in a different 
context, an aspect that will be investigated in future research. Moreover, the proposed 
methodology is sufficiently versatile to be applied to any hospital services, maintaining 
consistency given by the international perspective but adaptable to local needs. 
In conclusion, the proposed method aimed at assessing hospital service, integrating international expertsǯ know-how and specific needs at a local level, and designed for combining 
practical needs of the healthcare institution with rigor of scientific approach, resulted to be 
successful. Decision makers of the local panel declared they were very satisfied by the usage of 
the method, stating it was easy-to-use, valid and helpful tool for taking decisions. However, some 
minor issues (i.e., better definition of criteria) have still to be solved, and the approach has to be 
extended and validated in different contexts. 
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3.4 Final remarks 
This chapter analyzed hospital services, with the main purpose of finding an approach of 
assessment based on both scientific rigor and easiness-to-use from decision makersǯ perspective. 
A preliminary study aimed to assess a clinical engineering service through Multi-Criteria 
Decision Analysis; a second work aimed at studying a process considered crucial in the 
healthcare domain (i.e., process of surgical tools), through the application of lean management 
techniques, with the principle purpose to identify the main issues of the particular field of 
interest; the third study aimed at finding a useful tool for assessing the service previously 
studied in detail, following HTA approach and integrating Multi-Criteria Decision Analysis 
approach. 
The final work allowed to identify a versatile approach that can be used also in different 
contexts, based on both international findings and decision makersǯ needs to have an easy-to-use 
tool. This method is based on the criteria considered as most important at international level, 
and it is shaped on particular needs of the hospital where the service has to be implemented. 
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Chapter 4 
Medical equipment in Low Income 
Countries 
The final part of this work concerns a preliminary study of medical equipment to be 
assessed in Developing Countries. Even though it is on its preliminary stage, a research on the 
principal needs of Developing Countries related to medical devices was performed, and a 
possible solution for improving management of medical devices is proposed. The research study 
was presented in 2016 at the XVI National Congress of Italian Association of Clinical Engineers 
(AIIC) [213]. 
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4.1 Introduction 
HTA is increasingly used in low- and high-resource nations and an aim among HTA agencies 
and scientists in developed countries is to assist low-income countries to ǲadoptǳ future local 
HTA activities [214]. 
One of the most challenging aspects to be considered for introducing a new technology in hospitals is the identification of the most suitable solution, shaped on the actual usersǯ needs. 
Facing this issue is even more important and difficult in Developing Countries. Indeed, due to the 
lack of resources, avoiding waste of time and finding the most effective solution is crucial. 
Nevertheless, the literature states that medical technology-based projects are often implemented 
without sufficient assessment of local needs [215]. 
Even though nearly 80% of healthcare equipment available in some Developing Countries is 
donated or funded by international donors or foreign governments [216], only 10-30% of 
donated equipment becomes operational [217]. Reasons for unused equipment include 
mismanagement in the technology acquisition process, inefficient prioritization of available 
resources throughout the world, misalignment between the usersǯ needs and the adopted 
technologies, low availability of service and costs related to the technologies maintenance, 
cultural barriers, lack of user education and training, lack of spare parts, and lack of effective 
technical support [218] [219]. Summarizing, medical equipment are often donated regardless to 
the environment where they will have to operate. Moreover the personsǯ readiness to adopt a new technology is different from a place to 
another and it is deeply linked to cultural behaviors and personal predisposition. Another 
important and paradoxical aspect is related to the unsustainable costs of medical technology. 
Indeed, although more and more medical equipment manufacturers have moved towards 
Developing Countries (because of their cheaper labors), most of their productions still cost much higher than local productions and they cannot be directly sold in those countriesǯ markets: 
customers need to import those products after adding high tariff [220]. 
On the other hand, donors should be more aware of the challenges and needs of end-uses, 
and communication between donors and recipients about these challenges should be improved. 
As stated by WHO [218], the main aspects to be considered to prevent inadequate medical 
equipment donations are: 
 Donors lack awareness of the local realities of the intended recipients; 
 Donors and recipients often do not communicate as equal partners in the pursuit of a 
common goal; 
 Recipients have difficulty articulating to the donor how best they can be helped; 
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 The recipientǯs circumstances may lead them to believe that anything is better than 
nothing. 
The donation process is summarized in Figure 19, provided by WHO [218]. 
 
 
 
Figure 19 – Process for soliciting and offering donations of medical equipment (from  [218]) 
The introduction of HTA in Developing Countries and the assessment of medical equipment 
before donation can be considered as a key point. At the same time, the importance of adapting 
global knowledge to local context of the specific Low-Income Country within the assessment is 
recognized as crucial [214]. 
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4.2 The proposed solution 
The proposed approach [213] aims to serve as a support for managing donations in 
Developing Countries, addressing the main challenges at the state-of-the-art and following the 
process recommended by WHO presented in the previous paragraph. 
The proposed approach, briefly introduced in this paragraph, but not yet developed, is a 
web-based platform that serves as a meeting point between donors and solicitors, aimed at 
improving appropriateness in medical equipment donation. It can be divided into three main 
pars: Donors, Network and Donation Solicitors (Figure 20). 
 
 
Figure 20 – Main pars (Donors, Network and Donation Solicitors) of the web-based platform that serves as a meeting 
point between donors and solicitors, aimed at improving appropriateness in medical equipment donation 
First of all, a Network has to be created. The purpose of this approach, indeed, is to facilitate 
the interaction among actors already existing and interested in either medical equipment and 
supporting developing countries. This network can include, among others, corporations acting 
directly or through other organizations, individuals, non-governmental organizations (NGOs), 
associations devoted to developing countriesǯ needs, and companies or private professionals 
capable of providing useful services or products (e.g., trainers, translators, transporters). These 
actors join into a dedicated web portal, after a structured preliminary assessment aimed at 
identifying how the company/professional can be of support in the specific context of medical 
equipment provision in developing countries, with particular attention to the main gaps 
identified by WHO and previously described. The same portal allows the interaction and 
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consultation between health care facility and donor, in order to evaluate the actual possibility of 
a donation. 
The second part is dedicated to donors. A preliminary assessment of medical equipment to 
be donated is made through a checklist with a double purpose: 
 To identify medical equipment technical performance; 
 To verify the availability of guidance and documents related to medical equipment 
(e.g., user manual). 
After assessment completion, the medical equipment is tagged and labeled through 
keywords (e.g., related to diseases, intended use, departments) in order to help solicitors in 
identifying their needs. Categorization of keywords represents a complex and important issue, since they have to be extremely easy to be understood by solicitors and grouped under ǲfamiliarǳ 
names, better if accompanied by pictures designed to simplify understanding. At the end of this 
phase, the medical equipment is published online on the web portal. 
The third part is represented by donation solicitor. Solicitors express a need by choosing 
among the available keywords and groups aimed at facilitating the process of articulating how 
they can be helped. Otherwise, if solicitors already know which kind of medical equipment they 
need, they can directly search it through a dedicated search button. If the solicitor finds medical 
equipment of interest, they send a request to donor, and they directly interact each other.  
During this consultation, solicitor can share with donor the particular needs related to the 
specific local constraints and resources with donor, verifying whether the medical equipment 
addresses all their needs. Particularly, during the consultation between donor and solicitor they 
verify: 
 If the medical equipment addresses solicitorsǯ needs; 
 If medical staff capable of using the medical equipment is available; 
 If technical staff capable of maintaining and checking the medical equipment is 
available; 
 If user manual is written in a language they can understand. 
Hence, solicitor and donor manage together the assessment on both sides, following a 
comprehensive checklist that takes into consideration all the related aspects and needs for a 
proper donation, and underlying what is lacking.  
After their consultation, the lacking needs for a proper usage of the medical equipment are 
shared through the network and a call is launched through the web-platform. If someone among 
the actors involved in the network is able to be of support, they answer the call and become part 
of the medical equipment donation with their service/products, providing for example user 
manual translation, spare parts, transporting medical equipment, training medical or technical 
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staff (example in Figure 21). The process continues until the medical equipment completely 
addresses solicitorǯs needs and it is ready for a proper use.  
 
 
Figure 21 – Example of checks performed before donating medical equipment 
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4.3 Discussion 
Even though it is on its preliminary stage, the proposed approach and the medical 
equipment assessment would help the donation process, reducing wastes and providing support 
for proper donation. It aims to focus on essential features, similarly to frugal innovation 
purposes, with particular interest to the actual local needs.  
Moreover, it would serve as hub and help collaboration and cooperation among associations 
and organizations already devoted to supporting developing countries, as well as all the 
stakeholders involved into the process. 
Lastly, it would allow individuals to be and feel of help, through the leverage of their own 
competences and skills. 
Even though the proposed solution is not strictly based on HTA, it provides a structured 
approach for assessing medical equipment to be donated in Developing Countries, considering 
the most important aspects to be addressed for a proper donation, as highlighted by the World 
Health Organization.  
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Chapter 5 
Conclusions 
In this thesis, methodologies generally used for Health Technology Assessment and for 
reducing wastes, improving processes and services, were firstly investigated. Then, these 
methodologies were applied to both ǲclassicalǳ and innovative technologies, and they were 
modified according to specific needs, in order to combine scientific rigor with practical needs of 
decision makers. 
The investigated technologies are medical devices, divided into technologies already in the 
market and technologies not yet available, and hospital services. 
The investigated methodologies are Health Technology Assessment, divided into ǲtraditionalǳ (TA and horizon scanning; Multi-Criteria Decision Analysis, with a particular focus 
on PAPRIKA; and Lean Management, integrated with two other tools (i.e., Goal Question Metrics, 
and IDEF0) generally used in different sectors. 
The main challenges in using traditional HTA approach have been identified (Chapter 1), 
and the main issue in healthcare practice of its application concerns the time offset between the 
request of assessing technologies and the availability of final reports. This issue causes as 
important consequence the HTA misuse from decision makers. Another identified challenge 
concerns the lack of data in certain technologies not often studied in the literature, conversely to 
technologies most frequently assessed through HTA (e.g., drugs). From this perspective, HTA can 
be considered a useful methodology for assessing technologies only if reports are provided in a 
short time and if data for comparing different technologies are available in the literature. 
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If data are lacking in the literature, Multi-Criteria Decision Analysis can be considered as a 
useful support for assessing technologies, since it provides a prompt and valuable support for 
decision makers, for both qualitative and quantitative data. Within the present study, PAPRIKA 
was successfully used for assessing hospital services (Clinical Engineering Department in 
Paragraph 3.1, and CSSD in Paragraph 3.3), and it was considered a valuable tool from decision 
makers perspective. 
HTA approach strongly differs in relation to the particular kind of technologies, as presented 
in Chapters 2 and 3, where different technologies have been assessed. This result suits with the 
definition of HTA at the state-of-the-art, as presented in chapter 1, that emphasizes the 
heterogeneity of the methodology depending on the peculiarities of environment, settings and 
technologies to be assessed. Indeed, a standardized method for applying HTA is not available in 
the literature. In this thesis, a standardized approach was proposed for assessing health 
technologies whereas not sufficient data are available in the literature, exploiting Multi-Criteria 
Decision Analysis, and it was tested on a CSSD. 
Furthermore, regarding process improvement, IDEF0 was used for mapping the entire 
process of surgical tools, and lean management techniques, together with Goal Question Metric 
(GQM) for identifying the specific question to be addressed for improving the process, allowed to 
reduce wastes and to simulate a newest process with considerable cost saving (Paragraph 3.2). 
The integration of Lean techniques, IDEF0 and GMQ represents an innovative, versatile, 
reproducible, and successful approach. 
Even if the literature doesnǯt define ǲhospital serviceǳ as ǲhealth technologyǳ, some authors consider it as ǲtechnology assetǳ, hence to be included in the more traditional assessment, even 
though not much works in the field are still available in the literature. Indeed, investigation on 
CSSD put the basis for continuing the study and identifying an overall and comprehensive 
methodology combining HTA with MCDA approaches, and integrating international expertsǯ 
know-how with needs and peculiarities of the specific hospital at a local level. The swim-lane 
activity diagram of the proposed methodology, discussed in Paragraph 3.3, is presented in Figure 
22. 
The methodology was tested in an Italian healthcare authority and decision makers of the 
local panel declared they were very satisfied by the usage of the methodology that resulted to be 
easy-to-use and provided a rapid feedback. 
Moreover, an approach similar to Horizon Scanning, a branch of HTA dedicated to 
innovative technologies, was used in the present work for assessing and designing an innovative 
technology for patients with chronic conditions (Paragraph 2.2). The application of the 
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methodology allowed to identify opportunities in the market and to foresee requirements aimed 
to address specific needs of patients. 
 
 
Figure 22 – Swim-lane activity diagram of the proposed methodology for assessing hospital services 
Concluding, a simplified workflow of a path useful to Clinical Engineers from a practical 
perspective for selecting tools to be used for evaluating/assessing technologies within the 
healthcare domain can be briefly summarized as in Figure 23. 
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Figure 23 – Workflow of the proposed path for selecting tools to be used for evaluating/assessing technologies within the 
healthcare domain 
Starting from the need to evaluate or assess a technology within the healthcare domain, the 
first question suggests to identify the typology of technology. In case it is a drug or a clinical trial 
or a procedure that directly involves patients, many tools to be adopted are already available in 
the literature. 
If it is a medical device not yet in the market, horizon scanning approach can be adopted. 
This methodology can be exploited even for designed an innovative medical device, since it 
provides suggestions for identifying the most important features for letting the technology 
competitive in the market. An example is provided in Chapter 2.2. 
If medical device is already on the market, it has to be considered whether sufficient data for 
performing a robust review are available in the literature. If not, MCDA approach can be 
exploited and the method presented in chapter 3.3 can be as well applied in this specific case. If 
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sufficient data are available in the literature, classical HTA based, for example, on systematic 
review of the literature or meta-analysis can be performed. 
If technology is a hospital service (or procedures within hospital service), the first matter to 
be addressed is to understand whether decision makers want to compare the technology with 
other alternatives. If not, the attention has to be focused on process improvement techniques 
(e.g., lean management or Six Sigma), as presented in chapter 3.2. If decision makers want to 
consider other alternatives, the methodology presented in chapter 3.3 can be applied. 
In order to let the overall proposed methodology currently used, it should be tested in a 
larger context, involving diverse environments and professionals, acquiring their feedbacks on 
its usefulness and ease-of-use in healthcare practice. This is the goal of future work. 
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